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Abstract
We conducted a randomized controlled trial to evaluate patients undergoing a total hip
arthroplasty (THA) who were discharged from the hospital either on the day of surgery
(outpatient) or were admitted overnight following surgery (inpatient). Our primary outcome
was the rate of serious adverse events during the first three months postoperatively.
Secondary outcome measures included cost, patient satisfaction, functional outcomes, quality
of life and pain. We found no statistically significant difference between the two groups in
serious adverse events. We found that outpatient THA was less expensive from the
perspectives of the hospital and ministry of health; but the difference in cost was balanced by
a relatively equivalent increase in indirect expenditures paid by society. No other statistically
significant differences were found between groups. Based on the results from this
preliminary analysis of a larger ongoing study, outpatient THA is safe and can contribute to
significant cost savings.
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Chapter 1

1

Introduction

Total hip arthroplasty (THA) is an established and proven procedure used to treat patients
with advanced arthritis of the hip. Considered one of the most successful surgeries in
orthopaedics, studies have demonstrated a greater than 90% implant survival rate at 1520 years post-surgery1,2. For this reason and the increasing aging population, the demand
for THAs is growing rapidly. However, healthcare budgets are finite3, and thus we must
find a more cost effective manner to offer this treatment while maintaining patient safety.
A significant portion of the cost associated with THA is attributed to overnight
admission4,5; so much so that a number of surgical centers have started performing THAs
on an outpatient basis3,5-15. To improve the chances of successful outpatient THA,
clinicians have implemented changes to analgesia, the timing of physiotherapy, and
applied advanced surgical techniques5,16. Changes to surgical techniques includes
reducing muscle damage and careful hemostasis16,17, which leads to minimal soft tissue
damage. This in turn should reduce pain, enable early mobilization and faster return to
normal gait following surgery16,17.
Another common theme within the literature is that appropriate patient selection is
essential to ensure safe and successful outpatient THA5,18. Patients with pre-existing
comorbidities that put them at greater risk of adverse events during the immediate
postoperative period should not be included18. However, healthy patients with willing
caregivers have a greater chance of successful discharge on the same day of surgery
following a hip replacement16,18.
The primary concern with performing outpatient THAs is patient safety. An evaluation of
the serious adverse events that require re-admission to hospital or additional surgical
intervention during the first few postoperative days; possibly extending to the first three
months postoperative, can determine the safety of an outpatient THA pathway. With the
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constraint on healthcare resources, developing a successful outpatient THA pathway
opens up the potential for substantial cost savings from the perspective of the Ministry of
Health, the institution, and society.
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Chapter 2

2

Literature Review

This review focuses on four main areas of the literature: anatomy of the hip, osteoarthritis
(OA), total hip arthroplasty (THA), and outpatient THA. The first section pertaining to
anatomy focuses on the muscles, ligaments and nerves most frequently affected by
surgical procedures. The second section will discuss OA, including symptoms, causes,
diagnoses, treatments and the economic burden in Canada. The third section will discuss
total hip arthroplasty; a surgical treatment for late-stage hip OA. Specifically, we will
outline the history, the advantages and disadvantages of the direct anterior (DA)
approach, the cost of THA and the potential cost savings associated with decreasing the
length of stay (LOS) in the hospital following the procedure. Finally, we will review the
literature pertaining to same day discharge (outpatient) following THA and summarize
the complication rates, clinical outcomes, economic analyses, and variability within the
literature.

2.1 Anatomy of the Hip
The hip is a ball-and-socket synovial joint that is formed by the head of the femur and the
acetabulum of the pelvis. The hip is a multiaxial joint that is capable of multiple
movements and a large range of motion, including flexion, extension, abduction,
adduction, lateral and medial rotation, and circumduction19.
The acetabulum consists of three bony components: the ilium, ischium and pubic bones19.
It is a cup-shaped fossa on the lateral aspect of the pelvis. A fibrocartilage labrum is
attached to the edges of the acetabulum, which provides a deeper fossa and a more secure
articulation between the acetabulum and the head of the femur. This deepening of the
fossa improves the stability of the joint by holding the femoral head more securely and
preventing easy dislocation of the hip19.
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The transverse acetabular ligament bridges the acetabular notch and joins the ends of the
acetabular labrum, forming a complete ring19. Beneath this ligament is the acetabular
foramen. The transverse acetabular ligament helps deepen and constrict the acetabulum to
prevent inferior movement of the femoral head19.
Both the acetabulum and the femoral head are coated with hyaline cartilage, which
provides a smooth surface for movement of the joint. The exception is over a central
depression of the femoral head called the fovea19. This depression serves as an
attachment point for the only intracapsular ligament of the head of the femur
(ligamentum teres). The artery of the ligament of head of femur runs with the ligamentum
teres through the acetabular foramen to supply the femoral head19,20.
Surrounding the hip joint is a strong joint capsule. The capsule is attached proximally at
the labrum and the edge of the acetabular notch, and distally at the intertrochanteric line
and the neck of the femur19.
Reinforcing the capsular ligament are three extracapsular ligaments: iliofemoral ligament,
pubofemoral ligament, ischiofemoral ligament20,21. Anteriorly, the strong Y-shaped
iliofemoral ligament runs across the front of the hip joint, joining the anterior inferior
iliac spine (AIIS) and acetabulum proximally to the intertrochanteric line of the femur
distally. The iliofemoral ligament is the strongest ligament in the body and contributes to
maintaining posture and limiting joint hyperextension20.
The pubofemoral ligament reinforces the inferior and anterior surfaces of the joint. It
prevents excessive abduction and extension of the joint19.
The thinnest of the three ligaments is the ischiofemoral ligament, which is situated on the
posterior surface of the joint capsule21. It originates at the ischium of the pelvis and
inserts on the greater trochanter of the femur. The ischiofemoral ligament restricts
hyperextension of the femur at the hip joint21.

5

Innervation to the hip joint comes from several nerves that pass nearby. The femoral
nerve (L2 to L4) innervates the anterior portion of the hip joint22. The nerve to the
quadratus femoris (L4 to S1) innervates the posterior side of the hip joint. Finally, small
branches of the sciatic nerve (L4 to S3), obturator nerve (L2 to L4) and superior gluteal
nerve (L4 to S1) provide innervation to the hip joint22.
The medial and lateral circumflex femoral arteries, and the artery to the ligamentum teres
provide vascular supply to the hip joint23. The medial circumflex femoral artery provides
the majority of the arterial supply. Damage to this artery can result in avascular necrosis
of the femoral head19.
There are a number of muscles that help move and support the joint. These include
muscles on the anterior thigh, medial thigh, posterior thigh and gluteal region19.
The anterior compartment of the thigh is composed of the sartorius and quadriceps
femoris19. The sartorius originates at the ASIS and crosses obliquely to insert on the
medial aspect of the tibia in a three-pronged tendinous structure called the pes
anserinus20. The function of the sartorius is to abduct, medially rotate and flex the thigh19.
The femoris is comprised of four muscles, with the rectus femoris being the only muscle
that crosses the hip joint. The direct head of the rectus femoris originates at the anterior
inferior iliac spine (AIIS) and the indirect head originates at the hip capsule. These two
heads of the muscle insert at the base of the patella19,20. The rectus femoris crosses both
the hip and knee joint, thus it helps with both hip flexion and knee extension. The femoral
nerve innervates both the sartorius and rectus femoris19.
The muscles of the medial compartment of the thigh are pectineus, adductor longus,
adductor brevis, adductor magnus, gracilis and obturator externus19. These muscles
originate from the pubic rami and runs along the posterior shaft of the femur. With the
exception of obturator externus (lateral rotator), these muscles are the adductors of the
thigh19. The obturator nerve is the primary nerve that innervates the medial compartment
of the thigh19.
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Two other muscles of the hip are related to the anteromedial thigh: The tensor fascia latae
(TFL) and the iliopsoas19. The TFL originates on the crest of the iliac wing as well as at
the ASIS, and inserts on the iliotibila tract that attaches to the lateral condyle of the
tibia20,24. It acts to abduct, medially rotate and flex the thigh, while also helping to
stabilize the trunk on the thigh. The superior gluteal nerve (L4-L5) innervates the
TFL19,24.
The iliopsoas is formed from the union of the iliacus and psoas muscles19. This muscle
originates on the iliac fossa and lower spine in the posterior abdominal wall and enters
the anteromedial thigh beneath the inguinal ligament to insert onto the lesser trochanter
of the femur. The iliopsoas is the main flexor of the thigh at the hip joint and helps
stabilize the hip. The anterior rami of lumbar nerves (L1 to L3) innervates the iliopsoas19.
The lateral femoral cutaneous nerve (LFCN) innervates the skin on the lateral aspect of
the thigh20,25,26. This nerve is part of the lumbar plexus that arises from the dorsal aspect
of the second and third lumbar nerves. The LFCN emerges from the middle of the psoas
muscle and crosses the iliacus obliquely towards the ASIS25,26. It then passes underneath
the inguinal ligament and over the sartorius muscle, where it divides into an anterior and
posterior branch25,26. The anterior branch is distributed to the anterior and lateral parts of
the thigh. The posterior branch supplies the posterior aspect of the thigh, from the greater
trochanter to the middle of the thigh25,26.
The gluteal region consists of three large gluteal muscles and the deeper group of smaller
muscles. The large muscles include the gluteus maximum, gluteus medius and gluteus
minimus19. These muscles work to extend and abduct the thigh at the hip joint. The
deeper group is comprised of five muscles: piriformis, gemellus superior, obturator
internus, gemellus inferior, and quadratus femoris19. The deep muscles originate on the
lateral pelvis and insert on the greater trochanter of the femur. Their action is to
externally rotate the thigh at the hip joint and abduct the thigh when the limb is flexed.
Branches of the sacral plexus of nerves innervate the muscles of the gluteal region. The
superior (L4 to S1) and inferior (L5 to S2) gluteal nerves innervate the gluteal muscles19.
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Three other branches of the sacral plexus innervate the deeper muscles: the nerve to
piriformis (S1, S2), nerve to obturator internus (L5 to S2), and nerve to quadratus femoris
(L4 to S1)19.
The superior and inferior gemelli combine with the obturator internus to form the
conjoint tendon27. The tendons of these muscles join before inserting into the medial
aspect of the greater trochanter.
The posterior thigh is compromised of three hamstring muscles that originate from the
ischial tuberosity of the pelvis and insert onto the proximal tibia or fibula19. This group
consists of the semitendinosus, semimembranosus and biceps femoris. These muscles are
two-joint muscles, which act to extend the hip and flex the leg. The sciatic nerve (L5 to
S2) innervates the posterior thigh muscles19.

2.2 Osteoarthritis
Osteoarthritis (OA) is a degenerative joint disease that leads to the breakdown of articular
cartilage and the underlying bone28-30. This disease can result in pain, stiffness and loss of
function28-30. OA is commonly seen in weight-bearing joints, such as the knee and hip2831

. As OA progresses, there is usually visible asymmetric joint space narrowing on

radiographic imaging, as well as sclerosis, bone cysts and the breaking down of bone and
development of abnormal bony growths called osteophytes30. OA is the most prevalent
type of arthritis, affecting more than 10% (approximately 4.6 million) of Canadians28,29,31.
By 2036, this number is expected to grow to an estimated 7.5 million Canadians28,29,32.

2.2.1

Symptoms of OA

The symptoms of OA vary depending on the severity of the disease and which joint is
affected. However, common symptoms include pain, stiffness and limited range of
motion28. These symptoms can severely affect quality of life28. In weight-bearing joints,
OA commonly results in impaired mobility. These symptoms can cause patients to live a
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sedentary life, which can then lead to secondary complications such as obesity and heart
disease. This inactivity can also cause muscle weakness and impaired balance31.

2.2.2

Causes of OA

OA is commonly subdivided into either primary OA or secondary OA33. Primary OA
refers to a disease that is idiopathic in nature with multiple risk factors, such as obesity,
age, sex and genetics. Secondary OA is considered a systemic or localized disease,
caused by risk factors such as previous joint injury, Paget’s disease, or developmental
deformities33. It is not always possible to attribute a specific classification to an
individual with OA since recent literature suggests that certain cases of OA previously
considered primary are caused by minor developmental deformities34,35.
In obese patients, excess weight puts additional stress on weight-bearing joints, which
can be a predisposing factor for OA28,36. Furthermore, being overweight or obese can
affect your metabolism, also a suggested contributing factor for OA28,36. Individuals of
any age can develop OA, but the prevalence of OA increases with age28,32. Fifty-eight
percent of the individuals with OA are greater than 65 years of age32. Sex may be a
contributing risk factor to OA, as two out of three Canadians affected by arthritis are
women32. Previous joint injuries can damage the tissue of the joint28. These injuries can
contribute to muscular deconditioning, leading to increased joint loads and development
and progression of OA37. Finally, genetics can contribute to the development of OA, as
those with a family history of OA have an increased risk of developing the disease33.

2.2.3

Treatment for OA

OA is a progressive disease that tends to get worse over time28. Currently, there is no cure
for OA28,38. However, there are treatments available to manage symptoms. These
therapies have two main objectives: to relieve pain and to preserve function28,33,38. It is
recommended that patients with early-stage OA treat their disease with nonoperative
treatments, such as exercise, maintaining a healthy lifestyle and using pain and anti-
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inflammatory medications28,33,38. Patients with more severe OA generally require
operative treatment, such as joint replacement28.

2.2.4

Economic Burden of OA in Canada

In addition to the physical burden, OA poses a large economic burden on the Canadian
economy. Health-care costs and lost productivity associated with OA is estimated to be
close to $30 billion each year29. Projections expect the economic burden to double to $67
billion by 2031. Although OA is considered a condition that afflicts older adults, 12% of
workers in Canada currently have OA, and within a generation, it’s estimated that this
number will grow to almost 30% of workers.
Costs associated with OA are generally divided into direct costs (i.e. costs of visits to
health professionals, of procedures, and of investigative tests) and indirect costs (i.e. time
lost for paid work by patient or caregiver)39. In 2004, Maetzel et al.39 calculated that the
average total 6 month cost per patient with OA in Canada is $2856, with $1976 (69.2%)
associated with direct costs and $880 (30.8%) associated with indirect costs.
The rise in the aging population in Canada, coupled by the rising rates of obesity will
have significant consequences on the future of the Canadian health care system29. If
administered effectively, total joint replacements (TJR) can lead to significant cumulative
savings in both direct and indirect health care costs29. Patients undergoing a TJR can
expect a significant reduction in pain and improvement in quality of life, allowing many
to return to their regular daily activities. Studies have estimated that TJRs can result in
$1.5 billion cumulative savings over the next 10 years, and $14.3 billion saved over 30
years29.
In 2009, Hawker et al.40 conducted a population-based economic analysis to assess the
changes in direct health care costs, as well as pain and disability in patients who
underwent a primary TJR compared to matched controls who did not receive a TJR. This
study found that patients that underwent a TJR experienced reductions in pain and
disability (WOMAC post-pre p < 0.0001), as well as arthritis-attributable health care
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costs (p < 0.0001)40. The matched controls illustrated worsening of their general health
and their health care costs remained stable or increased (p = 0.80)40.

2.2.5

OA of the Hip

Hip OA is typically associated with hip pain that develops gradually and worsens with
weight-bearing activities33. During a physical exam, patients with hip OA generally
indicate pain in the groin area or buttocks and sometimes on the inside of the knee or
thigh33. The American College of Rheumatology has recommended that to diagnosis OA
of the hip, patients must present with hip pain and at least two of the following:
erythrocyte sedimentation rate of <20 mm/hr, radiographic femoral or acetabular
osteophyte formation, and radiographic joint-space narrowing33,41. Radiographic evidence
of hip OA is present in about 5% of the population over the age of 65 years33. Late-stage
OA of the hip is often characterized by both structural damage and patient reported pain,
stiffness and loss of function30. Total hip arthroplasty (THA) is recommended for patients
that demonstrate radiographic evidence of joint damage in conjunction with persistent
pain or disability42.

2.3 Total Hip Arthroplasty
In the 1960’s, Sir John Charnley pioneered modern THA43-45, which revolutionized the
treatment of advanced arthritis of the hip, by improving range of motion, stability and
quality of life44,45. Common diagnoses that are treated by THA include: osteoarthritis,
rheumatoid arthritis, acute hip fractures, developmental dysplasia, osteonecrosis, and
post-traumatic arthritis46.
THA is considered one of the most successful orthopaedic surgeries42,45. The demand for
THA is growing rapidly due to the proven success and increase in the aging population.
In Canada, there has been a 5-year increase of 19.1% (49,503 in 2013-2014 versus 41,473
in 2009-2010), and a 1-year increase of 5%46.
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In 2013-2014, age-standardized hospitalization rates for patients undergoing THA, aged
20 and older was 139 per 100,00046. There was a marked difference between males and
females, as males had an age-standardized rate of 127, while the females rate was 14846.
Even with the proven success of THA, there is always an inherent risk with any surgical
procedures. Since 2009-2010, 1.6% primary hip replacements were revised within the
first year, 2.0% were revised within two years and 2.4% were revised within 3 years46.
Although the risk for revision is low, the risk increases over time. The Canadian Joint
Replacement Registry in 2015 reported that the most common reason for revisions were
aseptic loosening (23.9%), infections (17.9%), instability (12.6%), bearing wear (8.9%),
periprosthetic fracture (6.5%) and others (14.7%)46.

2.3.1

Cost of THA

Although proven to be an effective treatment in reducing pain and functional limitations,
there are concerns over the large share of health care resources and high costs associated
with THA47. Several researchers have attempted to evaluate methods to reduce costs
without compromising patient safety and functional outcomes48.
For example, in 2004, Antoniuou et al.49 investigated three different public teaching
hospitals with 940 Canadian patients undergoing a THA and found that the average total
cost per procedure was $6766 ± $119; which included both direct and overhead costs.
The mean total cost for THA was significantly cheaper in Canada compared to the United
States ($6766 versus $13,339; p < 0.0001). A large contributor to the increase in cost in
American centers is the cost of the implant, which is approximately $8017 in the United
States and $1695 in Canada49.
Martineua and colleagues50 found that total costs associated with THA are greater in lowvolume (< 300 THA/year) compared to high-volume (> or = 300 THA/year) Canadian
hospitals. They reported figures in US dollars and concluded that high volume versus low
volume overhead costs were $1380 ± 35 versus $2432 ± 49, direct costs were $3023 ± 93
versus $4952 ± 91, and total costs were $4403 ± 117 versus $7385 ± 38, respectively50.
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Most of the disparity was the cost of the implant, as high volume centers tend to have
controlled unit costs per implant. This study concluded that for optimal cost containment,
THAs should be predominately performed in high-volume centers50. Further predictors
for increase in cost associated with THA are cerebrovascular disease (39.4% increase in
cost; p < 0.002), female sex (7% increase in cost; p < 0.01) and existing complications
(12.5% increase in cost; p < 0.04)50.

2.3.2

Length of Stay

A significant portion of the cost of THA comprises the LOS in hospital4. Similar to the
risk factors associated with increase in cost, predictors for increase in LOS comprise of
low-volume center (9.9% increase in LOS; p < 0.008), cerebrovascular disease (45.8%
increase in LOS; p < 0.0007), female sex (9.5% increase in LOS; p < 0.002) and
complications (24.8% increase in LOS; p < 0.0002)50. Although the cost of a THA is less
in Canada compared to the United States, Antoniuou et al.49 found that between 1999 and
2001 Canadian patients spent more time in the hospital compared to American patients
(7.2 versus 4.2 days; p < 0.0001).
In Canada, the median LOS in 2013-2014 was four days for both male and female hip
replacement recipients46. Although there has been a recent push towards decreasing the
LOS following hip replacements, the median LOS for both sexes has not changed over
the last year46; which is perhaps attributable to raised concerns that reducing LOS will
lead to suboptimal outcomes for other postoperative measures, such as increases in
readmission and revision rates48,51. However, Vorhies and colleagues48 retrospectively
assessed 1802 THA patients and concluded that there was no association between
decreasing LOS and increasing hospital readmissions. This finding was in agreement
with several other publications3,52,53.
To further contain the cost of THA, some have suggested that changes to clinical
pathways, like accelerated perioperative care and rehabilitation interventions, may be
cost-effective from the perspective of the patient, society and the Ministry of Health54,55.
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Specifically, in 2009, Larsen and colleagues55 found that the cost of their accelerated
program (education preoperatively and intensive mobilization postoperatively) was
approximately US $4000 less than their standard of care group (surgical information on
day of admission and gradual mobilization according to patient’s tolerance), with an
additional gain of 0.05 QALY. Similarly, Brunenberg and colleagues54 reported that costs
were lower (US $1261 per patient) and functional improvement was greater (p < 0.001)
when patients were fast-tracked by receiving a preassessment screening and preoperative
arrangements for home care compared to the standard of care whereby patients were not
screened and arrangement for care was addressed postoperative.
At our institution, the current length of stay for patients post THA is 2-3 days. This
relatively short LOS is potentiated by effective blood conservation leading to lower
transfusion rates, periarticular injections to help manage pain, improved patient
education, and early, aggressive physiotherapy on the day of surgery.

2.3.3

Direct Anterior Approach

Originated by Dr. Judet in 1947, the DA hip replacement became a novel approach to
facilitate exposure to the hip joint during an arthroplasty56,57. Originally, this approach
required the removal of the anterior TFL from the iliac crest and the release of the
piriformis56-58. However, the DA approach has been refined by Dr. Matta in 1996 to
allow exposure of both the head of the femur and the acetabulum through a single
incision intermuscular approach, that in about half of patients does not require a release
of any muscles or tendons58,59. This approach allows for consistent component
positioning and leg length resoration58.

2.3.3.1

Surgical Technique

The following DA surgical technique for THA is used at the University Hospital, London
Health Sciences Centre. This approach is performed using a modified Heuter approach60.
All DA surgeries are performed using a general anesthetic. The procedure begins by
positioning the patient supine on a specialized operative traction table (Hana fracture
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table; Mizuho OSI, Union City, California)59. The incision is made 2-4 cm lateral to the
ASIS (Figure 1). This incision is carried for 8-12 cm at 20 degrees from the sagittal plane
toward the lateral aspect of the ipsilateral knee59. Next, the LFCN is transposed medially
and protected and a plane is developed between the TFL and the sartorius. A hip retractor
is used to displace the rectus femoris medially and the gluteus medius laterally to expose
the anterior hip capsule59.
Once gentle traction is applied to the operative limb, a Muller retractor is used to perform
a capsulotomy to expose the femoral neck. A saw is used to make a femoral neck
osteotomy, and then a corkscrew removes the femoral head58,59.
Traction is released and the acetabulum is reamed to bleeding bone and appropriate depth
and diameter. The acetabular component is inserted with the use of an offset inserter
handle to minimize soft tissue trauma. Intraoperative fluoroscopy confirms and optimizes
the component position59. Once the final acetabular component is inserted, the operative
limb is carefully extended, adducted and externally rotated to facilitate accessibility to the
femur58. A bone hook elevates the proximal femur anteriorly. If the femur cannot be
sufficiently elevated, the conjoint tendon +/- piriformis is released to optimize
exposure59.
A double offset femoral broach handle permits easier access to the proximal femur during
preparation. After trialing using fluoroscopy to assess leg lengths and offset as well as
ensure appropriate stem size and alignment, the stem is then implanted into the femoral
canal and the final head is impacted onto the stem59. Once the final implants are in place,
the hip is reduced and fluoroscopy is used to ensure appropriate the implant positioning
and the leg lengths. The wound is sutured closed and sterile dressing is applied59.
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Figure 1: Location of skin incision for the direct anterior total hip arthroplasty
surgical approach
Reproduced with permission from: Petis et al. Surgical approach in primary total hip
arthroplasty: anatomy, technique and clinical outcomes, Canadian Journal of Surgery,
Vol. 58(2), pp. 128-139, 201559.

2.3.3.2

Advantages and Disadvantages of the DA Approach

From a clinical perspective, the DA approach provides several advantages to the
traditional posterolateral or lateral approaches. The posterolateral approach is associated
with a high dislocation rate and requires the division of the posterior capsule and external
rotators58,61. The lateral approach has demonstrated a lower dislocation rate, but requires
the detachment of the gluteus medius and minimus and is associated with abductor
dysfunction post-operatively58,62. The DA approach is an internervous approach to the hip
that avoids the dissection of muscles or tendons from bone, leaves the posterior capsule
intact, restores gait kinematics earlier, and results in a low dislocation rate25,26,58,59,63,64.
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Postoperative dislocation rates following a THA occur in between 0.4% and 12% of
patients58,64,65. However, Matta et al.58 performed 494 THA done through the DA
approach and noted an overall dislocation rate of 0.61%, which is in accordance with a
dislocation rate of 0.96% reported by Siguier and colleague64.
Conversely, the DA approach is associated with an increase in complications associated
with the lateral femoral cutaneous nerve (LFCN), which can cause reduced sensation to
the anterolateral thigh66. Bhargava and colleagues25 noted that LFCN impairment
occurred in 12/81 patients (14.8%) undergoing a DA THA, however permanent
impairment occurred in only 2/81 (<3%) and the majority of these cases resolved by one
year post-surgery. Goulding et al.26 reported a significantly higher incidence of LFCN
impairment in patients undergoing a DA THA (37/55, 67%). However, it did not lead to
functional limitations compared to asymptomatic patients26. In addition, we have found
that patients with an elevated body mass index (BMI) (>40 kg/m2) are at a greater risk of
wound complications associated with the anterior approach and are advised to undergo
other approaches, such as lateral or posterior59.
Finally, most surgeons using the DA approach prefer to use a specialized operating table
(Figure 2) and intraoperative fluoroscopy66 to improve component positioning and ensure
leg lengths are more accurate58,67. While the specialized orthopaedic table allows for
rotational control of the femur and facilitates femoral exposure with minimal muscle
trauma, the additional intraoperative fluoroscopy helps lower the dislocation rate by
optimizing both the acetabular and femoral component positioning58,59. Other surgical
approaches do not use specialized tables or intraoperative fluoroscopy. These factors can
be costly and hinder the technique’s generalizability across hospitals25,63,66.
From a cost savings perspective, several studies have suggested that the DA approach
reduces LOS and promotes earlier functional recovery following surgery59,66,68,69. At our
institution, Petis et al.66 conducted an economic analysis of differing surgical approaches
and found that the mean hospital LOS was significantly shorter with the DA approach
(33.9 hours; 95% CI; 29.6-38.2) vs. lateral (64.2 hours; 95% CI, 56.7-71.7; p < 0.001)
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and DA vs. posterior approach (65.8 hours; 95% CI, 56.7-74.8; p < 0.001). This reduced
LOS resulted in a significantly reduced cost compared to other surgical approaches. The
overall costs (in 2013 Canadian dollars), including intraoperative costs and hospital stay,
were significantly less for the DA approach ($7300.22; 95% confidence interval [CI],
7064.49-7535.95) vs. lateral ($7853.10; 95% CI, 7577.29-8128.91; p = .031) or posterior
approach ($8287.46; 95% CI, 7906.42-8668.51; p < 0.001)66.
Interestingly, when costs are compartmentalized, intraoperative cost of operating room
time (2013 Canadian dollars) was significantly more expensive for the DA approach
(1729.90; 95% CI, 1668.14-1791.66) vs. lateral (1435.24; 95% CI, 1336.83-1533.65; p <
0.001) or posterior approach (1629.92; 95% CI, 1532.29-1727.55; p < 0.001)66. Similarly,
total cost of procedure was significantly more expensive for the DA approach ($5799.79;
95% CI, 5718.52-5881.06) vs. lateral ($5274.39; 95% CI, 5158.55-5390.24; p < 0.001)
vs. posterior approach ($5274.39; 95% CI, 5158.55-5390.24; p < 0.001)66.
Even with the additional operative costs, including the specialized table that has a 5-year
longevity66 ($120 000 in 2013 Canadian dollars) and intraoperative fluoroscopy, the DA
approach leads to a reduced overall cost. Patients undergoing a DA hip replacement can
be discharged earlier from the hospital due to reduced postoperative pain, earlier
functional recovery and quicker restoration of normalized gait66,69. From the perspective
of the hospital, the significant reduction in LOS translates into significant cost savings66.
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Figure 2: Specialized operative traction table (Hana fracture table, Mizuho OSI)
used during a direct anterior total hip arthroplasty
Reproduced with permission from: Petis et al. Surgical approach in primary total hip
arthroplasty: anatomy, technique and clinical outcomes, Canadian Journal of Surgery,
Vol. 58(2), pp. 128-139, 201559.

2.4 Outpatient versus Inpatient THA
We conducted a systematic review of the literature to determine the safety and feasibility
of outpatient joint replacement surgery (Figure 3)16. The majority of studies included
within our systematic review reported complication, revision and readmission rates16. In
the literature, there is a clear distinction between acute complications either intraoperative
or immediately postoperative and the long-term complications that occur outside the
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hospital. In general, the case series investigating the safety and feasibility of outpatient
joint replacements reported low complication rates ranging from 0/160 (0%)70 to 38/150
(25.3%)14 during the acute phase, and 0/100 (0%)8 to 8/86 (9.4)71 for long-term
complications. Lovald et al.72 outlined that the majority of adverse events suffered by
patients undergoing outpatient joint replacement surgery are accidental falls, urinary
retention, infection, deep vein thrombosis, joint pain, joint stiffness and wound
complications.
More importantly, the comparison studies did not show a higher complication rate for
outpatient procedures compared to inpatient procedures. As readmission rates are
increasingly used as a performance indicator, there is concern that outpatient surgery may
increase readmission rates. However, Lovald et al.72 illustrated that in a Medicare sample
from 1997-2009, readmissions were similar between outpatient TKA (n = 454) and
standard 3-4 day stay TKA (n = 71,341) at 90 days (p = 0.13), 1 year (p = 0.10) and 2
years (p = 0.75) post surgery. Similarly, in both comparison studies investigating
outpatient THAs3,10, no difference was found in complication rates between the inpatient
and outpatient groups.
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Study

Year

Type of Study

Control Group

Experimental
Group

Mean
Duration of
Follow-up

Outcomes

Conclusion

2-incision
technique is
safe and
facilitates a
rapid patient
recovery
Rapid
rehabilitation
protocol is safe
and fulfills the
potential
benefits of a
rapid recovery

THA studies
Non-comparative
observational
studies
Berger6

2003

Consecutive
case series

NA

Outpatient THA
(n = 100)

1 yr

Readmissions,
radiographic findings,
complications,
component placement

Berger et al.8

2004

Consecutive
case series

NA

Outpatient THA
(n = 100)

3 mo

Berger et al.14

2009

Consecutive
case series

NA

Outpatient THA
(n = 150)

3 mo

Readmissions,
complications, HHS,
SF-12 score,
radiographic findings,
return to activities
(driving, work,
walking
independently,
walking one-half mile)
HHS, satisfaction,
complications,
readmissions

Berry et al.9

2003

Consecutive
case series

NA

Outpatient THA
(n = 200)

1 yr

Complications,
revisions,
readmissions

Chen and
Berger12

2013

Consecutive
case series

NA

Outpatient THA
(n = 86)

3 mo

Readmissions,
complications

Dorr et al.13

2010

Consecutive
case series

NA

Outpatient THA
(n = 53)

6 mo

Mears et al.15

2009

Consecutive
case series
(therapeutic)

NA

Outpatient THA
(295)

3 mo

Complications,
readmissions,
satisfaction, pain
scores, functional data,
HHS
Readmissions,
complications

2014

Therapeutic
study (casecontrol)

Inpatient
THA (n = 78)

Outpatient THA
(n = 119)

1 yr

Comparative
studies
Aynardi et
al.3

Length of stay, final
cost (USD),
complications,
readmissions

Outpatient
THA can be
safely
performed in
select patients
Outpatient
THA can be
safely
performed in
select patients
Outpatient
THA can be
safely
performed in
select patients
Outpatient
THA can be
safely
performed in
select patients
Outpatient
THA can be
safely
performed in
select patients
Outpatient
THA can be
safely
performed in
select patients
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2005

Prospective
economic
analysis
(cohort study)

Inpatient
THA (n = 10)

Outpatient THA
(n = 10)

1 yr

Cost, complications

Outpatient
THA is
financially
advantageous

TKA and UKA
studies
Non-comparative
observational
studies
Berger et al.73

2006

Consecutive
case series

NA

Outpatient TKA
(n = 50)

3 mo

Complications,
readmission, range of
motion

Berger et al.71

2009

Consecutive
case series

NA

Outpatient TKA
(n = 86) and
outpatient UKA
(n = 25)

3 mo

Readmissions,
complications

Cross and
Berger74

2014

Retrospective
case series

NA

Outpatient UKA
(n = 105)

3 mo

Complications,
readmissions

Dervin et al.75

2012

Consecutive
case series

NA

Outpatient UKA
(n = 24)

6 mo

Adverse events, pain
scores, medication
diaries, range of
motion, WOMAC,
KOOS

Gondusky et
al.70

2014

Consecutive
case series

NA

Outpatient UKA
(n = 160)

1 yr

Lovald et al.76

2014

Retrospective
case series

NA

Outpatient or
short-stay TKA
(n = 5,401)

1 yr

Complications,
extension, flexion,
KSCRS functional
score, KSCRS knee
score, KSCRS total
score
Mortality,
readmission, revision,
complications,
accidental falls, pain
and stiffness

Outpatient TKA
can be safely
performed in
select patients
Outpatient TKA
and UKA are
feasible in
large
percentage of
patients
Large cohort of
unselected
patients had
successful
outpatient UKA
Continuous
femoral nerve
block can be
used in select
patients to
assist
outpatient UKA
Outpatient
UKA can be
safely
performed in
select patients

2009

Prognostic
study (cohort
study)

Inpatient
TKA (n = 64)

Outpatient TKA
(n = 64)

2 yr

2014

Retrospective
cohort

3 to 4-day
TKA (n =
71,341)

Outpatient TKA
(n = 454)

2 yr

Bertin10

Comparative
studies
Kolisek et
al.77

Lovald et al.
72

*NA = not applicable

Length of stay,
readmission, adverse
events, Knee Society
knee score, Knee
Society function score,
range of motion,
satisfaction
Cost, mortality,
readmission, revision,
postoperative
complications

Outpatient TKA
can be safely
performed in
select patients

Outpatient TKA
can be safely
performed in
select patients

Outpatient TKA
can be safely
performed in
select patients
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Figure 3: Articles Included in Systematic Review
Reproduced with permission from: Pollock et al., Outpatient total hip arthroplasty, total
knee arthroplasty, and unicompartmental knee arthroplasty - a systematic review of the
literature. JBJS Reviews. (in press).16

2.4.1

Optimal Patient Selection

For successful outpatient THA surgery, a number of studies conclude that careful patient
selection is necessary (e.g., restrictions on age, BMI and severity of comorbidities). Six
studies10,15,71,72,74,76 included in our systematic review recruited an unselected population,
where all patients undergoing a joint replacement were included. These were largely
feasibility studies10,15,71,74 or studies retrospectively examining the Medicare database72,76.
The purpose of these studies was not to suggest that outpatient joint replacements are
appropriate for all patients, but rather to identify factors associated with a longer hospital
stay. Both Mears et al.15 and Bozic et al.78 identified four factors: 1) female sex (p <
0.001), 2) increasing age (p < 0.001), 3) increasing blood loss (p < 0.001) and 4) an ASA
classification of 3 or 4 (p < 0.01). Supplementary literature investigating fast-track
pathways following THA have identified additional risk factors that are associated with
prolonged hospital stay: existing comorbidities, preoperative use of walking aids, obesity,
longer incision length, and longer operative time4,48,52,53,79.

2.4.2

Clinical Outcomes

Three case series reported on clinical outcomes following outpatient hip
replacements8,14,80. Dewelius et al.80 discharged 90 patients within twenty-four hours of
surgery and reported that Harris Hip scores improved from 52 points preoperatively to 90
points at one year postoperatively, which is similar to improvements reported following
inpatient care81,82. Two similar studies by Berger and colleagues8,14 reported similar
improvements for patients undergoing outpatient THA. Specifically, in their first case
series, Berger et al.8 recruited 100 consecutive patients, with 97 patients meeting the
criteria for same day discharge. Mean Harris Hip scores improved from 56 points (range,
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32-77) preoperatively to 91 points (range, 61-100) at 3 weeks (p < 0.001), 94 points
(range, 79-100) at 6 weeks (p < 0.001), and 96 points (range, 74-100 points) at 3 months
postoperatively (p < 0.001)8. In a second case series, Berger et al.14 discharged 150
patients on the same day of surgery following a hip replacement and reported that mean
Harris Hip scores improved from 51 points preoperatively (range, 32-74) to 91 points
(range, 56-100) at 6 weeks (p < 0.01) and 95 points (range 62-100) at 3 months
postoperatively (p < 0.01).
Two studies evaluated satisfaction post outpatient THA13,14. Berger et al.14 assessed
satisfaction at 2-weeks postoperatively by asking the question, “would you be discharged
home the same day following the same clinical pathway again?”14. Of the 150 patients
included, 144 patients were satisfied, while 5 patients were dissatisfied due to
postoperative nausea, and one patient was dissatisfied due to postoperative pain14. Dorr et
al.13 administered a 6-item questionnaire at the patient’s 6-week follow up visit of 53
patients. Of the 52 patients that completed the questionnaire, 96% would have same day
surgery again, 19% reported that postoperative pain was a problem, 87% claimed that
outpatient THA gave them more confidence and accelerated their recovery, and 94% of
patients would recommend same day surgery to others.
In contrast to previously reported publications77,83, Lovald et al.72 found that in certain
instances there were less favourable outcomes for the shorter stay groups following TKA.
The authors attributed this finding to sites that implemented outpatient protocols before
their clinical teams were ready; recommending that institutions should gradually reduce
the length of stay until the clinical staff is comfortable performing joint replacements in
an outpatient setting71,72.

2.4.3

Economic Benefits

One of the benefits of the movement towards outpatient joint replacements is the
potential for considerable cost savings. Two economic analyses concluded that there is a
marked decrease in costs associated with outpatient THA compared to inpatient THA3,10.
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Aynardi et al.3 illustrated that the overall cost in the outpatient setting was significantly
lower than inpatient, $24,529 versus $31,327 (p = 0.0001). Bertin10 found that the total
average charge for the outpatient group, including preoperative, intraoperative and
postoperative charges, was approximately $2500 less than for the inpatients.

2.4.4

Limitations of the Current Literature

We found that surgical techniques vary across outpatient THA literature16. For studies
that specifically defined their surgical technique, there was one study that used direct
anterior Smith-Peterson3, four studies that used two-incision6,8,9,14, one study that used
posterolateral10, one study that used antereolateral Watson-Jones12, and one study that
used posterior MIS13. Differences in operation time, blood loss, and type of anaesthesia
exist depending on the technique used. These differences could account for differing
perioperative care and cause expertise bias. Further, according to the Cochrane Risk of
Bias Assessment Tool for Non-Randomized Studies of Interventions (ACROBATNRSI)84, the quality of the studies included in our systematic review was poor (Figures 4
and 5).
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Study
Aynardi et al.3
Bertin10
Kolisek et al.77
Lovald et al.72

Evidence of
Selection
Bias/Prognostic
Imbalance
High risk
Moderate risk
High risk
Low risk

Bias Due to
Confounding
Factors?
High risk
High risk
High risk
Moderate risk

Was Assessment
of Outcomes
Precisely
Measured or
Unbiased?
Moderate risk
Moderate risk
Low risk
Low risk

Was Followup of
Participants
Sufficiently
Complete?
Low risk
Low risk
Low risk
Low risk

Bias Due to
Selection of
Reported
Results or Due
to Missing
Data?
Low risk
Low risk
Moderate risk
Low risk

Comparability of
Cohorts on
Important
Confounding
Factors
High risk
Low risk
Moderate risk
Moderate risk

Figure 4: Risk-of-Bias Assessment of Comparative Studies in Systematic Review
Reproduced with permission from: Pollock et al., Outpatient total hip arthroplasty, total
knee arthroplasty, and unicompartmental knee arthroplasty - a systematic review of the
literature. JBJS Reviews. (in press).16

Study

Berger6
Berger et al.8
Berger et al.73
Berger et al.14
Berger et al.71
Berry et al.9
Chen and Berger12
Cross and Berger74
Dervin et al.75
Dorr et al.13
Gondusky et al.70
Lovald et al.76
Mears et al.15

Evidence of
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Bias/Prognostic
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Weak
Weak
Weak
Weak
Moderate
Weak
Weak
Moderate
Weak
Weak
Weak
Strong
Strong

Study
Design
Weak
Weak
Weak
Weak
Weak
Weak
Weak
Weak
Weak
Weak
Weak
Weak
Weak

Bias Due to
Confounding
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Moderate
Moderate
Moderate
Weak
Moderate
Weak
Weak
Moderate
Weak
Weak
Weak
Moderate
Strong

Was Assessment
of Outcomes
Precisely Measured
or Unbiased?
Moderate
Strong
Strong
Moderate
Strong
Strong
Moderate
Strong
Strong
Strong
Strong
Strong
Weak

Was Follow-up
of Participants
Sufficiently
Complete?
Strong
Strong
Strong
Strong
Strong
Strong
Strong
Strong
Strong
Moderate
Strong
Strong
Strong

Was There
Blinding of the
Outcome
Assessor and
Study
Participants?
Weak
Weak
Weak
Weak
Weak
Weak
Weak
Weak
Weak
Weak
Weak
Weak
Weak

Figure 5: Quality Assessment of Non-Comparative Observational Studies in the
Systematic Review
Reproduced with permission from: Pollock et al., Outpatient total hip arthroplasty, total
knee arthroplasty, and unicompartmental knee arthroplasty - a systematic review of the
literature. JBJS Reviews. (in press).16
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Finally, our systematic review found evidence of gender inequality in the current
outpatient joint replacement literature16. The majority of studies in the systematic review
had more males than females in the outpatient cohorts. However, as of 2013-2014 in
Canada, patients undergoing arthroplasties were more frequently female than male for
both hips (58.4%) and knees (60.2%)46. The under-representation of females in outpatient
studies could be related to gender differences in patient characteristics, ability to
manipulate gait aids, societal roles in terms of caregiving, or a potential underlying
gender bias by the surgeon toward males in their preliminary outpatient trials.

2.5 Summary
The disease burden of hip OA continues to increase rapidly. For late-stage hip OA, THA
is a proven and effective treatment to relieve pain, restore function and improve quality
of life. However, it is imperative to develop pathways to ensure the health care system
operates efficiently. The literature demonstrates that one of the most costly aspects of hip
replacements is the length of hospital stay following the procedure. There are a limited
number of published studies that have evaluated a fast-track pathway and demonstrated
that a reduction in LOS leads to significant cost savings. A less invasive surgical
approach and selection of the optimal patient may allow for safe outpatient THA.
Two studies have compared outpatient THA to an inpatient cohort3,10. Both of these
studies were prospective cohort studies that included a cost analysis. In both instances,
outpatient THA was safely performed on appropriately selected patients at a substantial
cost savings. However, the sample sizes were small and neither study randomized their
patient populations.
Reducing the cost of healthcare improves access to services for both patients and
healthcare centers. In addition to the potential cost savings, in certain physician-owned
centers in the United States there is an increased payment gained by the physician when
joint replacements are performed on an outpatient basis. Thus, these centers are
motivated to perform THA as an outpatient procedure. Therefore, it is timely to perform a
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randomized trial with high methodological rigor to determine whether outpatient THA is
safe and financially advantageous.
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Chapter 3

3

Objectives

Our primary research objective was to compare the rate of serious adverse events during
the first three months postoperative following a total hip arthroplasty (THA) using either
the inpatient or outpatient model of care. We defined serious adverse events based on
U.S. Food and Drug Administration (FDA) criteria as any event when the patient
outcome is death, life-threatening, hospitalization (initial or prolonged), and disability or
permanent damage85.
Our secondary objectives were to compare inpatient and outpatient THA using the
following outcomes: cost; patient satisfaction; functional outcomes; quality of life; pain;
and the extent of assistance provided by the caregiver.
We tested the hypothesis that the rate of serious adverse events in patients following an
outpatient care pathway would not be different to the rate in patients following an
inpatient care pathway during the first three months post-THA. We also hypothesized
that there would be a significant cost savings associated with outpatient care but no other
differences between the two care pathways for patient satisfaction, functional outcomes,
quality of life, pain or caregiver assistance.
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Chapter 4

4

Materials and Methods

4.1 Study Design
This was a single-centre randomized controlled trial (RCT) that took place in London,
Ontario. The study involved patients undergoing a primary total hip arthroplasty through
the direct anterior (DA) surgical approach. Study participants were randomly allocated to
be discharge on the day of surgery (outpatient) or admitted to the hospital overnight
following surgery (inpatient). Patients consented to study participation at their initial
consultation, which took place up to six months prior to surgery. Baseline assessments
were performed at the patients’ pre-admission clinic visit, which took place within one
month prior to surgery. Follow-up assessments occurred according to the standard
postoperative visit schedule at our centre for this surgery. This study was approved by the
University of Western Ontario Health Sciences Research Ethics Board and took place at
the London Health Sciences Centre (LHSC), University Hospital between June 2015 and
June 2016.

4.2 Eligibility Criteria
Patients were eligible for this study if they were undergoing a primary unilateral total hip
arthroplasty using the DA approach. Patients were ineligible for participation if they lived
further than a 60 minute drive from the institution, had an ASA score greater than 3,
significant pain management issues, a history of anesthesia related complications, obesity
that significantly impacted their ability to mobilize, pannus that limits adequate wound
exposure for healing, anaphylaxis to penicillin, significant psycho / social issues that
prevented the patient from managing safely at home, or cognitive issues that precluded
the ability to understand instructions or to give informed consent. Patients were also
ineligible if they lacked an appropriate social network to provide them with assistance
during the immediate postoperative period. There were no formal age restrictions, but it
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was up to the participating surgeon’s discretion whether the patient was deemed
medically fit for same day discharge.

4.3 Treatments
Patients undergoing a primary DA THA were discharged either on day 0 (outpatient) or
were admitted to the hospital overnight (inpatient). For the participating surgeon, both
treatments were standard of care. Perioperative care protocols and the frequency of
follow-up visits were identical between groups. All patients were required to meet the
hospital standard discharge criteria before being sent home following surgery. To meet
the discharge criteria, a patient must be capable of using the required gait aid, have
appropriate pain control, an absence of nausea and vomiting, be free of excess bleeding,
be alert and oriented, meet the appropriate targets from physiotherapy for discharge, have
possession of take-home medications, and be in the company of a caregiver.

4.4 Methods to Reduce Bias
4.4.1

Randomization

Patients were approached about study participation at their initial consultation after the
investigating surgeon deemed the patient eligible for outpatient care. Once consented, the
patient was randomized to one of two groups (outpatient or inpatient), using a computer
generated 1:1 randomization scheme, in permuted blocks of two or four, with
stratification by previous joint replacement (either contralateral THA, ipsilateral TKA or
contralateral TKA).

4.4.2

Blinding

We blinded patients to the fact that they were part of a randomized trial. To maintain the
blind, we asked all participating health care staff (surgeons, nurses, physiotherapists,
residents, fellows etc.) to withhold from the patient that their discharge pathway was
randomly assigned for the purpose of this study. It is our opinion that knowledge of
randomization would threaten the feasibility and validity of this study. Although patients
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were blinded to the randomization, they were told an approximate discharge date prior to
surgery to ensure they received the necessary pre-operative education and had made the
appropriate plans with caregivers. Because patients were assessed on the day of
discharge, the research assistant was not blind to group allocation. However, since the
outcomes measures were patient-reported and the research assistant used standardized
instructions while interacting with patients, we were not concerned with observer bias.

4.4.3

Modified Zelen Design

The ethical justification for a Zelen study design86 is that both study groups received
standard of care and thus, patients were not put at increased risk through randomization.
The original single non-consent design described by Zelen86 does not complete the
consent process for patients who are randomized to a standard of care intervention.
In this study, there were two modifications to the Zelen design. The first was to ask
patients to consent to participation in a study where every aspect of the study is fully
described with the exception of the randomization or the between-groups objectives. The
second modification was to conduct a debriefing session with the patient upon
completion of the study protocol. At three months post-surgery, patients were fully
informed about their random allocation to inpatient or outpatient surgery and why this
study design was felt appropriate. Afterwards, we asked patients for their consent to use
their data in the between-group comparisons.
We felt that the Zelen design was necessary to reduce bias introduced by the patient or
caregiver’s preference for one discharge pathway over the other. From the costing
perspective, a patient sent home the same day, who is aware that others remain inhospital may be more likely to return to hospital through the emergency department, even
though it is extremely rare for urgent complications to occur within the first two weeks
following THA. This is a costly decision from the institution’s perspective. In contrast,
we know anecdotally that patients who stay overnight in hospital postoperative who fit
our eligibility criteria could have managed at home and might have been more
comfortable had they been discharged as an outpatient.
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Furthermore, this study design is imperative to ensure validity in patient-reported
outcomes like satisfaction, functional ability and quality of life. If patients randomized to
inpatient THA knew that other patients were discharged the same day, they could feel
dissatisfied simply because they feel that going home would have been the preferred
option. Alternatively, patients allocated to the inpatient group may feel more satisfied if
they felt they had better care, greater access to the surgeon or better pain control while inhospital. On the other hand, if patients in the outpatient group knew that other patients
remained as inpatients, they may feel more satisfied knowing that they were able to go
home and recover with greater privacy in the comforts of their own home in the company
of their family/friends while other patients remained in a ward room.

4.4.4

Intention to Treat

Patients were not randomized until the surgeon deemed the patient eligible for
participation. At the patient’s pre-admission appointment, both the nursing staff and
physiotherapist met with the patient to further assess their eligibility.
If a patient randomized to the outpatient protocol requested to stay longer in the hospital
or did not meet the discharge criteria for outpatient care such as severe comorbidities or
inadequate caregiver assistance, then the patient followed the inpatient protocol.
Moreover, if a patient randomized to the inpatient protocol was adamant on being
discharged from the hospital on the same day of surgery, then the patient followed the
outpatient protocol. As per the intention to treat principle, we analyzed all patients
according to the group to which they were randomly allocated regardless of whether their
discharge pathway was adhered to following surgery.

4.4.5

Standardization of Intervention

Both treatment groups were considered standard-of-care for the participating surgeon. In
both groups, each patient received the same postoperative mobility and care instructions
from a physiotherapist and education from a nurse but the timing of these interventions
was focused during the preoperative appointment for those randomized to outpatient care
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and postoperative for those randomized to inpatient care. During the physiotherapy
consult, all patients underwent a mobility assessment, and were instructed on crutch
walking and exercises required for successful recovery post-surgery.

4.5 Outcome Measures
Once patients consented to participate in the study, the study coordinator registered the
patients into the secure web-based data management system (EmPower Health Research,
Inc, www.empowerhealthresearch.ca). Patients had the option of either logging into the
online system to directly access their questionnaires or to receive hard copies of the
questionnaires at each appointment. We measured all patients preoperatively at the
preadmission appointment (within one month prior to surgery), on the day of discharge
from hospital, and at two weeks, six weeks and three months post-operative.

4.5.1

Primary Outcome Measure

The primary outcome was any serious adverse event within the first three months
postoperative. We adopted the Food and Drug Administration’s (FDA) definition of
serious adverse, which includes re-admission to hospital, additional surgical intervention,
disability or permanent damages, life threatening adverse event, or death85. Events of
interest include deep infection, deep vein thrombosis, dislocation, periprosthetic fracture,
pulmonary embolism, myocardial infarction, urinary retention, and death.

4.5.2

Secondary Outcome Measures

Secondary outcome measures included cost, patient satisfaction, expectations, patientreported disease-specific health-related quality of life (HRQOL), functional outcomes,
general health and extent of caregiver assistance.

4.5.2.1

Hospital Cost

We recorded all surgical procedure related costs, as well as total length of stay in the
hospital. This queried details of the patient’s care pathway following surgery, including
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the time spent in PACU, day surgery (for outpatient group) and the orthopaedic inpatient
unit (for inpatient group).

4.5.2.1.1

Patient Costs

We asked patients to keep a daily diary to record any costs they incurred related to their
hip for the first two weeks following discharge from the hospital. This included any
medication use, assistance from others, the amount of time from paid employment their
caregivers required to provide care, any additional costs associated with the hip
replacement, and daily pain scores.

4.5.2.1.2

Healthcare Resource Use

Patients recorded any healthcare use regarding their hip replacement at each of their
follow up visits post-surgery. The cost form consisted of 14 patient-reported domains:
emergency room visits and hospitalization, family doctor visits, specialist visits and
outpatient clinics, health care professional visits, tests, procedures and surgeries,
prescription medications, over-the-counter medications, employment status and time-off
work from paid employment, caregiver employment status and time-off from paid
employment, change in employment status, homemaking and volunteer activities,
assistance from others, assistance living, and any other miscellaneous costs.

4.5.2.1.3

Sources of Cost Data

We obtained the unit cost for all hospital related resources from LHSC’s case costing
department. The cost of the physician, specialist, clinic, laboratory tests and medical
procedures were collected from the Ontario Ministry of Health Schedule of Benefits and
we obtained the cost of drugs from the Ontario Drug Benefit Formulary. For patients less
than 65 years of age, patients self-reported any prescription drug costs.
We standardized the operating room costs for each surgery. This includes implants and
additional surgical equipment. We included the costs specific to a direct anterior
including the specialized table, lead aprons and intra-operative fluoroscopy. The
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fluoroscopy was monetized on a per-minute basis and included both the direct and
indirect costs of the technician and use of the machine.
We used the average Canadian wage reported by Statistics Canada to account for time off
of paid employment for both patients and their caregiver. The current value of minimum
wage in Ontario accounted for lost time for patients or caregivers who were retired, or
those who lost time from volunteer or home making activities.

4.5.2.2

Patient Satisfaction

Published opinions regarding the measurement of patient satisfaction suggest that greater
validity comes with questions that inquire about satisfaction with a specific component of
the experience rather than the experience in general87-89. However, there are no reliable or
validated questionnaires regarding satisfaction following THA. Therefore, we constructed
a questionnaire consisting of 20 questions pertaining to satisfaction with pain control,
safety, quality of care and privacy. Each question was either rated on a 100-mm visual
analogue scale (VAS) or on a five-seven point ordinal scale (completely satisfied to
completely unsatisfied). Patients were only asked to fill out this questionnaire at their two
week follow-up visit, as the questions were geared towards assessing the patient’s
satisfaction with their care pre-operatively, and immediately post-operatively.
Additionally, patients were asked to report their satisfaction with the entire experience at
each of their postoperative visits. Specifically, we asked five questions querying
satisfaction with pain while sitting and lying down, hip function when getting out of bed,
performing light household duties and leisure activities. Each question included five
ordinal response options (very satisfied, satisfied, neutral, dissatisfied, very dissatisfied).

4.5.2.3

Expectations

Expectations were assessed pre- and post-operatively. Before surgery, patients were
asked the degree of pain relief and functional ability expected following the surgery (a
lot, somewhat, a little, no expectation). Post-operatively, patients were asked whether

36

they felt their preoperative expectations with respect to pain control and function were
too high, met, or too low.

4.5.2.4

Euro-QoL

To measure utility, we used the European Quality of Life Scale (Euro-QoL). The EuroQoL comprises of two sections, the EQ-5D index and the EQ-5D visual analogue scale
(VAS). The EQ-5D index is a self-administered five-item generic measure of HRQOL
that includes domains of mobility, self-care, usual activities, pain and discomfort and
anxiety and depression. Each item is scored using a five-point response scale and can be
converted to a utility value from 0 (worst) to 1.0 (best) using a scoring formula. The EQ5D VAS is a 0 (worst) to 100 (best) scale that assesses patient-perceived health status.
The results from the EQ-5D can be used for economic evaluation to measure utility and
calculate each patient’s quality-adjusted life year (QALY). In patients undergoing hip
replacements, the Euro-QoL has been shown to be valid and reliable90.

4.5.2.5

Western Ontario McMaster Osteoarthritis Index

The WOMAC is a 24-item self-administered questionnaire that measures symptoms and
physical disability for people with osteoarthritis that consists of three sections; pain,
stiffness and daily activities. Each question is rated on a five-point ordinal scale, ranging
from zero (none) to four (extreme). There are five questions regarding pain, two related
to stiffness, and 17 related to physical function. The maximum score for the pain,
stiffness, and physical function domains are 20 points, eight and 68 where a higher score
indicates better outcome. A global score can be computed by summing the scores for the
three subscales91.
This outcome measure has been tested and found to be valid, reliable and sensitive for
detecting important health changes post-surgery91. The WOMAC demonstrates
convergent construct validity with numerous impairment and disability measures (ex.
Harris Hip Score and Short Form-36)91. Regarding responsiveness, there was a large
effect size calculated for all three subscales (1.7-2.58, 1.0-2.17 and 1.8-2.9,
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respectively)91. Online data collection is similar to traditional paper methods and each
method can be used interchangeably without a significant effect on criterion validity92.

4.5.2.6

Harris Hip Score

The Harris hip score (HHS) is a valid and reliable measure administered by the surgeon
to study the clinical outcomes of hip replacements. There are ten items that cover the
domains of pain, function, absence of deformity and range of motion. It is a diseasespecific test that gives a maximum total score of 100, with the higher scores indicating
better results. Previous reports have indicated that a total score below 70 points represents
a poor result93.
Reports have illustrated that the HHS has high convergent validity with both the
WOMAC and 36-Item Short-Form Health Survey. The HHS has excellent test re-test
reliability (ICC=0.94) and inter-observer reliability (ICC=0.74-1.00)94.

4.5.2.7

Short Form-12

The Short Form 12 (SF-12) is a patient-reported measure that is used to measure healthrelated quality of life. It consists of a 12-question health survey monitoring outcomes
following surgery. Each question is rated on a three-to-five point ordinal scale with
separate scores for physical and mental function. Higher scores indicate better health and
function.
Reliability of the SF-12 is good for both the physical (ICC=0.84) and mental (ICC=0.80)
sections. For patients undergoing THA, the minimal detectable change is 12.18 for the
physical section, and 14.14 for the mental section95. Similar to WOMAC, electric
versions of SF-12 are comparable to paper versions when administered to joint
arthroplasty patients92.

4.5.2.8

Visual Analog Scale

The Visual Analog Scale is a self-administered pain assessment. Patients indicate their
pain on a ten-centimetre continuous scale that ranges from zero to ten, where zero
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represents no pain, and ten represents the worst pain imaginable. At discharge from the
hospital, patients mark their average pain since their surgery. At every other visit, patients
mark their average pain over the past week.
Test-retest reliability for this scale has been shown to be excellent (r = 0.94,)96. In terms
of construct validity, the VAS is highly correlated to verbal descriptive scales and
numeric rating scales, with correlations ranging from 0.71-078 and 0.62-0.91,
respectively96.

4.5.2.9

Pain Catastrophizing Scale

The Pain Catastrophizing Scale (PCS) is a 13-item patient-reported instrument used to
assess patient’s level of catastrophic thinking. Each question is rated on a five-point
ordinal scale, spanning from zero (not at all) to four (all the time). The PCS is comprised
of three subscales that assess rumination, magnification and helplessness. Either the score
can be computed for each subscale separately, or a total score encompassing the whole
PCS. Patients were asked to complete this questionnaire at their pre-admission visit. It
has shown adequate to excellent internal consistency for the total PCS (0.87), rumination
(0.87), magnification (0.66), and helplessness (0.78)97.

4.5.2.10 Self-Efficacy for Managing Chronic Disease
The Self-Efficacy for Managing Chronic Disease questionnaire is a patient-reported
questionnaire assessing how confident patients are in doing certain activities. This is a
six-item instrument, each comprising of a ten-point ordinal scale, ranging from one (not
at all confident) to ten (totally confident). Higher numbers indicate greater self-efficacy.
The score for the scale is the mean of the six items. The self-efficacy questionnaire was
administered at the patient’s pre-admission visit. Internal consistency reliability is
excellent (0.91)98.
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4.5.2.11 Caregiver Assistance Scale
Caregiver assistance was measured using the Caregiver Assistance Scale (CAS)99. The
CAS is comprised of 17 questions assessing the degree of assistance provided by the
caregiver for a variety of tasks throughout the recovery period. The scale ranges from
zero (no assistance provided) to six (a lot of assistance provided). We also collected
demographic information for each caregiver to evaluate whether the caregiver’s
responses are influenced by their sex, gender role or their relationship with the patient.

4.5.2.12 Patient Characteristics and Surgical Details
We collected demographic data, including date of birth, gender, BMI, smoking status,
comorbidities, and working status to evaluate the between-group similarities. We also
recorded anaesthesia time, surgical time, and blood loss for each procedure. Furthermore,
we asked patients to record any calls made by them or their caregiver to the surgeon’s
office, on-call resident or orthopaedic outpatient clinic. Finally, we asked patients to
report when they discontinued the use gait aids.

4.6 Sample Size
Based on the investigating surgeon’s current practice loads, we estimated that 140
patients would be eligible during the study period. As the risk of serious adverse event
following THA is low, it is not feasible to recruit a sufficient sample size to detect a
difference in event rates during the study period. Therefore, we did not conduct a formal
sample size calculation; rather we conducted this study using a convenience sample of
140 patients.

4.7 Data Analysis
We used SPSS version 23.0 to perform the analysis. We used descriptive statistics to
present the demographic characteristics of the patients in each treatment group using
means and standard deviations for continuous variables (age, BMI) and proportions for
nominal variables (sex, operative hip, previous THA, dominant side).
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For the primary outcome of early serious adverse events, we first determined the absolute
risk of adverse events in each group. We then calculated the relative risk (RR) with 95%
confidence intervals around the estimate.
We used an ANCOVA test for all outcome measures with a baseline measurement (EQ5D, WOMAC, SF-12, HHS, Pain NRS) to determine whether there was a statistically
significant difference between groups. The independent variable was the group (inpatient
or outpatient), the dependent variable was the outcome measure score and the covariates
were baseline measurements.
Graphically, we presented a plot of each outcome measure over time with each group as a
separate line and included 95% confidence intervals. Time zero represented baseline
measurements.
We presented the mean and standard deviation for all continuous data (Satisfaction, EQ5D, WOMAC, SF-12, HHS, Pain NRS, Pain Catastrophizing, Self-Efficacy and CAS) for
each group at each time point and then calculated mean between-group differences with
95% confidence intervals around the estimate. All tests were two-sided with p ≤ 0.05
indicating statistical significance.
We tested the assumptions for ANCOVA, which are normality, homogeneity of variance,
random independent samples, and the relationship between the dependent variable and
covariate is linear. To test for normality, we plotted a histogram of each outcome and
assessed the results for skewness and kurtosis. If the assumption of normality was not
met, we performed a Mann-Whitney U non-parametric test to establish the robustness of
our results.

4.7.1

Cost Effectiveness Analysis

We conducted a cost-effectiveness analysis from three perspectives: 1) public health care
payer (Ontario Ministry of Health), 2) the hospital, and 3) society. The health care payer
perspective included any direct health costs covered by our publicly funded system. This
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includes hospital, procedure related, surgeon, clinician and other health-care provider
time, test procedures or surgeries, and medications for patients on disability or aged 65
years and older. In addition to these costs, the societal perspective includes any out-ofpocket costs to the patient (such as physical therapy, medication, or assistive devices not
covered by the provincial insurance plan), as well as any indirect costs such as time
involved with appointments, time off of employment for patients or caregivers, as well as
time off from homemaking or caregiving activities as a result of the intervention.
We calculated the incremental cost-effectiveness ratio (ICER), with early postoperative
complications as the effectiveness measure. The ICER represents the ratio of incremental
cost (mean difference in cost between the two groups) to incremental effects (mean
difference in serious adverse event rate between the two groups). This ratio provides an
estimate of the additional cost per complication avoided.
We conducted a sensitivity analysis to examine the degree of uncertainty in our cost
analysis. Specifically, we assigned patient’s average daily income as both the patient
reported household income per 8-hour workday and as minimum wage ($11.25 per hour,
$90 per 8 hour work day). Furthermore, we assigned minimum wage to caregiver time off
of work. Finally, we assigned $0 to days off of homemaking activities instead of
minimum wage.

4.7.2

Missing Data

For missing end point data we used the last outcome carried forward, and for missing
midpoint data we used the mean of the group for that time point.

42

Chapter 5

5

Results

5.1 Patient Flow
Figure 6 outlines the flow of participants through each stage of the study. From June
2015 to May 2016, 172 patients were screened for eligibility, 67 were ineligible, eight
declined to participate and two eligible patients were enrolled in another study and
therefore excluded.
At the time of analysis, 43 patients had fully completed the study protocol to threemonths post-operative. One patient in the inpatient group withdrew from the study
following surgery because of an unwillingness to complete the study’s forms. A second
patient in the inpatient group was withdrawn from the study after suffering a
periprosthetic intraoperative fracture that led to an extended hospital stay.
Four patients received the intervention assigned to the other group (contamination).
Specifically, two patients in the inpatient group requested same day discharge and two
patients in the outpatient group required additional monitoring and the physiotherapists
recommended they be admitted overnight. These patients are analyzed according to the
intention-to-treat principle.

43

Assessed for Eligibility
(n=172)
Enrolled (n=95)
Included in
Analysis

Inpatient
(n=23)
Inpatient (n=21)
Outpatient (n=2)

Outpatient
(n=22)
Inpatient (n=2)
Outpatient (n=20)

Discharge (n=21)
Missed (n=0)

Discharge (n=22)
Missed (n=0)

2 Weeks (n=21)
Missed (n=0)

2 Weeks (n=22)
Missed (n=0)

6 Weeks (n=21)
Missed (n=0)

6 Weeks (n=22)
Missed (n=0)

3 Months (n=21)
Missed (n=1)

Ineligible (n=67)
Preexisting comorbidity (n=33)
Lives too far away (n=24)
Surgery cancelled (n=6)
Insufficient caregiver support (n=1)
Myocardial infarction prior to surgry (n=1)
Changed to lateral approach (n=2)
Declined to participate (n=8)
Enrolled in another study (n=2)

3 Months (n=22)
Missed (n=1)

Figure 6: Participant flow through the study
*The first 43 patients to complete follow-up were included in this analysis, including the
four crossover patients
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5.2 Demographic Information
Preoperative demographic characteristics and comorbidities were similar between the two
groups (Table 1).
Table 1: Baseline demographics for inpatient and outpatient total hip arthroplasty
Characteristic

Inpatient
(n=21)
12 (57)
62.1 ± 8.5 (45-79)
27.6 ± 5.9 (18-39)
9 (43)
5 (24)
18 (86)

Outpatient
(n=22)
12 (55)
60.2 ± 9.1 (37-75)
26.5 ± 4.8 (16-37)
12 (55)
8 (36)
17 (77)

Sex, n (%) Male
Mean Age ± SD, y (min-max)
Mean BMI ± SD, kg/m2 (min-max)
Operative Hip, n (%) Right
Symptoms in Other Hip, n (%)
Dominant Side, n (%) Right
Employment Status, n (%)
Currently Working
10 (48)
13 (59)
Unemployed
2 (9)
1 (5)
Retired
9 (43)
8 (36)
Previous Joint Replacement, n (%)
4 (19)
7 (32)
ASA Status, n (%)
1
3 (16)
4 (18)
2
11 (52)
14 (64)
3
7 (33)
4 (18)
4
0 (0)
0 (0)
Pain Catastrophizing Mean Score ± SE
15.2 ± 2.9
14.9 ± 2.7
Self-Efficacy Mean Score ± SE
7.2 ± 0.5
7.3 ± 0.4
Abbreviations. SD = standard deviation. BMI = body mass index. ASA = American
Society of Anesthesiologists physical status.

5.3 Surgical Characteristics
All participants underwent a primary THA through the direct anterior approach with
general anaesthesia. Surgical characteristics were similar between the two groups (Table
2).
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Table 2: Surgical characteristics for inpatient and outpatient total hip arthroplasty
Characteristics

Inpatient
(n=21)

Outpatient
(n=22)

Releases, n (%)ǂ
Conjoint Tendon
9 (43)
11 (50)
Piriformis
3 (14)
3 (14)
TFL
1 (5)
2 (9)
Posterior Capsule
1 (5)
2 (9)
Mean Operative Time ± SD, min§
72.3 ± 9.2
73.5 ± 10.5
Abbreviations. SD = standard deviation. ǂTwo patients in the inpatient group received two
intraoperative releases, while three patients in the outpatient group received two
intraoperative releases. §Operative time calculated from first incision to application of
dressing.

5.4 Pathway Flow: Admission to Discharge
Table 3 presents the length of stay in the hospital and time in post-anesthesia care unit
(PACU) for both groups. Patients in the inpatient group recovered in the ward after being
discharged from PACU, whereas patients in the outpatient group recovered in day
surgery after being discharged from PACU. The inpatient group experienced a longer
stay in PACU because they were often required to wait for a bed to become available,
whereas the outpatient group simply needed to wait until the day surgery unit was ready
for them. The median length of stay on the ward for the inpatient group was 22.5 hours
(IQR=7.6), while the median length of stay in the day surgery unit for the outpatient
group was 3.3 hours (IQR=1.1)
Two patients in the inpatient group were discharged on the second post-operative day.
One patient had a vasovagal episode and persistent dizziness post-operatively and
remained in hospital an extra day for observation. The second patient presented with
hypotension post-surgery which slowed their progression to gain mobility. This patient
was kept in the hospital an extra day and declared fit for discharge by the physiotherapist
on the second post-operative day.

46

Table 3: Pathway flow from admission to discharge for inpatient and outpatient
total hip arthroplasty
Inpatient (median ±
Outpatient (median ±
IQR)
IQR)
Length of stay (hrs)
29.1 ± 6.0
8.4 ± 1.1
Time in PACU (hrs)
2.3 ± 3.3
1.8 ± 1.0
Abbreviations. IQR = interquartile range. PACU = post anaesthesia care unit

p-Value
<0.001
0.01

5.5 Primary Outcome
5.5.1

Serious Adverse Events

The relative risk for serious adverse events was similar between groups (RR = 0.96, 95%
CI = 0.11 to 8.52, p = 0.97). Specifically, one patient in the inpatient group and one
patient in the outpatient group suffered a serious adverse event (Table 4). In the inpatient
group, one patient developed an infection approximately one week post-surgery and was
prescribed antibiotics for one week (Keflex). Unfortunately the infection did not resolve
and the incision continued to breakdown inciting an irrigation and debridement poly
exchange revision surgery three weeks following the primary hip replacement. The
patient was subsequently discharged after five days. Intraoperative cultures were positive
for Staphylococcus aureus and the patient was treated with Ancef for six weeks. The
infection resolved following this treatment.
One patient in the outpatient group misunderstood the prescription for analgesia and
presented to the emergency room by ambulance suffering an overdose two days postsurgery. The symptoms resolved quickly. At the two-week follow-up visit, this patient
had no significant pain control issues.
Table 4: Serious adverse events for inpatient and outpatient total hip arthroplasty
Group
Age
Gender
BMI
Inpatient
68
Female
30.6
Outpatient 62
Female
24.3
Abbreviations. BMI = Body mass index

Complication
Deep infection
Analgesia overdose
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5.6 Secondary Outcomes
5.6.1

Cost

The outpatient group was significantly less expensive than the inpatient group from the
perspective of the hospital (mean difference = $766; 95% CI = $68.82 to $1466.30) and
the Ministry of Health (mean difference = $850.77, 95% CI = $21.07 to $1680.47).
However, there was no statistically significant difference between the two groups from
the societal perspective (Table 5). Similar results were found with non-parametric MannWhitney U tests. There were no statistically significant differences between groups
regarding days off of work, days off of homemaking activities and caregiver assistance
(Table 6).
We originally planned to calculate the incremental cost-effectiveness ratio (ICER), with
early postoperative complications as the effectiveness measure. However, since there
were no differences in the rate of serious adverse events between the two groups, our
analysis simplified to a cost-minimization analysis.
Table 5: Cost from the perspective of the Ministry of Health, the hospital and
society for inpatient and outpatient total hip arthroplasty
Perspective
Hospital
Ministry of
Health
Society

Inpatient
(mean ± SE)
5169.76 ± 348.56
6751.59 ± 412.96

Outpatient
(mean ± SE)
4403.20 ± 63.41
5900.82 ± 76.82

Mean Difference
(95% CI)
766.56 (68.82 to 1466.30)
850.77 (21.07 to 1680.47)

12792.46 ± 1355.52 14483.08 ± 1857.52 -1690.62 (-6345.74 to
2964.50)
Abbreviations. SE = standard error, CI = Confidence interval

pvalue
0.03
0.04
0.47
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Table 6: Days off of work, days off of homemaking activities, and caregiver
assistance for inpatient and outpatient total hip arthroplasty
Inpatient
Outpatient
(mean ± SE) (mean ± SE)

Mean Difference
(95% CI)

Days off of work
21.1 ± 6.1
32.7 ± 8.2 -11.6 (-32.6 to 9.3)
(days)
Days off of
5.8 ± 1.5
4.6 ± 1.6
1.2 (-3.2 to 5.6)
homemaking (days)
Caregiver assistance
24.9 ± 4.2
28.2 ± 5.7 -3.4 (-17.7 to 10.9)
(hours)
Abbreviations. SE = standard error, CI = Confidence interval

5.6.1.1

pvalue
0.28
0.59
0.74

Sensitivity Analyses

Our results were similar when we assigned the wage for patient days off of work as the
patient reported household income per 8 hour work day, when we assigned minimum
wage ($11.25 per hour, $90 per 8 hour work day) to caregiver time off of work and when
we assigned $0 to patient days off of homemaking activities. However, the mean
difference between groups from the societal perspective became more similar when we
assigned minimum wage ($11.25 per hour, $90 per 8 hour work day) as the wage for
patient days off of work (mean difference = $77.51, 95% CI = $-1876.36 to $2031.39).

5.6.2

Patient Satisfaction

We split the results of our 20-item questionnaire into two tables; Table 7 illustrates the
results of the five questions with a VAS response option format and Table 8 reports the
results of the 15 items with Likert-type response options. There were no differences
between the two groups for any of the questions. Notably, almost all study participants in
both groups felt very strongly about recommending this procedure to a friend or family
member.
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Table 7: Patient satisfaction on a visual analog scale (VAS) at two weeks postoperatively following inpatient and outpatient total hip arthroplasty. Lower values
indicate greater satisfaction.
Question

Inpatient
(median ± IQR)

Outpatient
(median ± IQR)

p-Value

1. How much stress did you experience
10 ± 37
5 ± 50
0.95
due to uncontrolled pain after your
surgery?
2. How bad were the side effects from
36 ± 57
39 ± 72
0.81
the pain medication?
3. Overall, I would rate the quality of
2±9
1±2
0.10
care that I received before surgery as:
4. Overall, I would rate the quality of
3 ± 11
1±3
0.24
care that I received after surgery as:
5. How strongly would you feel about
1±0
1±1
0.45
recommending this procedure (THA)
to a friend or family member?
Abbreviations. IQR = interquartile range. All questions scored on a visual analog scale
between 0-100.
Most interestingly, 18/21 inpatients and 19/22 outpatients felt that their stay was the right
length and 20/21 inpatients and 22/22 outpatients were either mostly or completely
satisfied with all factors of the surgical experience. All patients enrolled in the study
indicated that they were either very likely or completely likely to have this procedure
again in the future in the same manner.
Table 8: Patient Satisfaction two weeks postoperatively following inpatient and
outpatient total hip arthroplasty
Patient Satisfaction

Inpatient
(n=21)

Outpatient
(n=22)

Upon discharge from the hospital, how safe did you feel
moving about the house, including going to the bathroom?
Completely Unsafe
Unsafe
Somewhat unsafe
Neither safe nor unsafe
Somewhat safe
Safe

0 (0)
0 (0)
4 (19)
0 (0)
3 (14)
6 (29)

1 (4)
1 (4)
0 (0)
1 (4)
5 (24)
6 (27)
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Completely safe

8 (38)

8 (37)

0 (0)
0 (0)
1 (5)
0 (0)
3 (14)
12 (57)
5 (24)

0 (0)
0 (0)
0 (0)
0 (0)
1 (4)
7 (32)
14 (64)

0 (0)
0 (0)
0 (0)
0 (0)
3 (14)
13 (62)
5 (24)

0 (0)
0 (0)
0 (0)
0 (0)
5 (23)
8 (36)
9 (41)

1 (5)
0 (0)
0 (0)
0 (0)
1 (5)
3 (14)
16 (76)

0 (0)
0 (0)
0 (0)
0 (0)
0 (0)
3 (14)
19 (86)

2 (10)
19 (90)

2 (9)
20 (91)

3 (14)
18 (86)

3 (14)
19 (86)

1 (5)
0 (0)

1 (4)
1 (4)

After surgery, the overall effectiveness of the pain control
medication received in the hospital were…?
Completely ineffective
Mostly ineffective
Somewhat ineffective
Neither effective nor ineffective
Somewhat effective
Mostly effective
Completely effective

After surgery, the overall effectiveness of the pain control
medication taken at home were…?
Completely ineffective
Mostly ineffective
Somewhat ineffective
Neither effective nor ineffective
Somewhat effective
Mostly effective
Completely effective

How would you rate the overall quality of nursing care that
you received in the hospital?
Completely dissatisfied
Mostly dissatisfied
Somewhat dissatisfied
Neither satisfied nor dissatisfied
Somewhat satisfied
Mostly satisfied
Completely satisfied

Did you have any questions or concerns about your surgery
or postoperative care that were not addressed before
surgery?
Yes
No

Did you have any questions or concerns about your surgery
or postoperative care that were not addressed after your
surgery, but before discharge from hospital?
Yes
No

Do you feel you were given enough information to know
what to expect after you were discharged in terms of
rehabilitation?
Completely dissatisfied
Mostly dissatisfied
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Somewhat dissatisfied
Neither satisfied nor dissatisfied
Somewhat satisfied
Mostly satisfied
Completely satisfied

Do you feel you were given enough information to know
what to expect after you were discharged in terms of
dressing change?
Somewhat dissatisfied
Neither satisfied nor dissatisfied
Somewhat satisfied
Mostly satisfied
Completely satisfied

Do you feel you were given enough information to know
what to expect after you were discharged in terms of the
amount of pain?
Completely dissatisfied
Mostly dissatisfied
Somewhat dissatisfied
Neither satisfied nor dissatisfied
Somewhat satisfied
Mostly satisfied
Completely satisfied

0 (0)
0 (0)
1 (5)
11 (52)
8 (38)

0 (0)
0 (0)
1 (4)
7 (32)
12 (56)

0 (0)
1 (5)
2 (10)
7 (33)
11 (52)

1 (5)
0 (0)
1 (5)
6 (27)
14 (63)

0 (0)
0 (0)
1 (5)
0 (0)
0 (0)
12 (57)
8 (38)

1 (5)
0 (0)
2 (9)
2 (9)
2 (9)
7 (32)
8 (36)

0 (0)
1 (5)
18 (85)
0 (0)
2 (10)

1 (5)
2 (9)
19 (86)
0 (0)
0 (0)

0 (0)
1 (5)
0 (0)
1 (5)
1 (5)
5 (24)
13 (61)

3 (13)
0
1 (5)
1 (5)
0
2 (9)
15 (68)

0 (0)
0 (0)

2 (9)
0 (0)

Consider the length of time you stayed in the hospital. My
length of stay was:
I would have preferred to stay another day or two
I would have preferred to stay a few more hours to another day
My stay was just right
I would have preferred to go home a day or a few hours sooner
I would have preferred to go home the same day as my procedure

Did you receive adequate feedback from your surgeon
regarding the results of your surgery (i.e., in the recovery
room, ward)?
Completely dissatisfied
Mostly dissatisfied
Somewhat dissatisfied
Neither satisfied nor dissatisfied
Somewhat satisfied
Mostly satisfied
Completely satisfied

Was your surgeon available and easily accessible if you
needed him or her after your surgery?
Completely dissatisfied
Mostly dissatisfied
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Somewhat dissatisfied
Neither satisfied nor dissatisfied
Somewhat satisfied
Mostly satisfied
Completely satisfied

0 (0)
1 (5)
0 (0)
5 (24)
15 (71)

0 (0)
2 (9)
0 (0)
3 (14)
15 (68)

1 (5)
5 (24)
7 (33)
3 (14)
3 (14)
2 (10)

2 (9)
1 (4)
3 (14)
3 (14)
7 (32)
6 (27)

1 (5)
0 (0)
0 (0)
0 (0)
0 (0)
6 (28)
14 (67)

0 (0)
0 (0)
0 (0)
0 (0)
0 (0)
4 (18)
18 (82)

0 (0)
0 (0)
0 (0)
2 (10)
19 (90)

0 (0)
0 (0)
0 (0)
3 (14)
19 (86)

Please comment on the quality of sleep you achieved on the
first night following your surgery:
I didn’t get any sleep
I awoke feeling very unrested
I awoke feeling somewhat unrested
Neutral
I awoke feeling somewhat rested
I awoke feeling very rested

Considering all factors (i.e., preoperative teaching, nursing,
doctors, hospital), how satisfied were you as a patient with
the arthroplasty surgery, from the time you first met the
surgeon and including up until the second week after your
surgery?
Completely dissatisfied
Mostly dissatisfied
Somewhat dissatisfied
Neither satisfied nor dissatisfied
Somewhat satisfied
Mostly satisfied
Completely satisfied

If you had a choice, how willing would you be to have this
procedure (THA) done again under the same
circumstances?
Not at all likely
Slightly likely
Moderately likely
Very likely
Completely likely

Finally, we assessed patient satisfaction regarding pain and function levels at six weeks
and three months post-operatively (Table 9). There were no significant differences found
between the two groups at either time-point. Responses to all questions were similar
between six weeks and three months post-operatively for both groups.
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Table 9: Patient satisfaction at six weeks and three months following inpatient and
outpatient total hip arthroplasty
Time
6 Weeks

Patient Satisfaction

Inpatient
(n=21)

Outpatient
(n=22)

Pain level while sitting?
Very Dissatisfied
Dissatisfied
Neutral
Satisfied
Very Satisfied

0 (0)
0 (0)
0 (0)
7 (33)
14 (67)

0 (0)
0 (0)
1 (5)
4 (18)
17 (77)

0 (0)
1 (5)
0 (0)
6 (29)
14 (67)

0 (0)
0 (0)
1 (5)
8 (36)
13 (59)

0 (0)
0 (0)
2 (10)
8 (38)
11 (52)

0 (0)
0 (0)
1 (5)
7 (31)
14 (64)

0 (0)
0 (0)
1 (5)
8 (38)
12 (57)

0 (0)
0 (0)
3 (14)
6 (27)
13 (59)

0 (0)
1 (5)
4 (19)
4 (19)
12 (57)

0 (0)
0 (0)
7 (32)
5 (23)
10 (45)

0 (0)
0 (0)
1 (5)
4 (19)
16 (76)

0 (0)
0 (0)
1 (5)
5 (23)
16 (73)

Pain level while lying in bed?
Very Dissatisfied
Dissatisfied
Neutral
Satisfied
Very Satisfied

Pain level while getting out of bed?
Very Dissatisfied
Dissatisfied
Neutral
Satisfied
Very Satisfied

Pain level while performing light household duties?
Very Dissatisfied
Dissatisfied
Neutral
Satisfied
Very Satisfied

Pain level while performing leisure recreational
activities?
Very Dissatisfied
Dissatisfied
Neutral
Satisfied
Very Satisfied

3 Months Pain level while sitting?
Very dissatisfied
Dissatisfied
Neutral
Satisfied
Very Satisfied

Pain level while lying in bed?
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Very dissatisfied
Dissatisfied
Neutral
Satisfied
Very Satisfied

0 (0)
0 (0)
1 (5)
8 (38)
12 (57)

0 (0)
0 (0)
1 (5)
7 (31)
14 (64)

0 (0)
1 (5)
1 (5)
5 (23)
14 (67)

0 (0)
0 (0)
1 (5)
6 (27)
15 (68)

1 (5)
1 (5)
1 (5)
4 (18)
14 (67)

0 (0)
0 (0)
1 (5)
8 (36)
13 (59)

1 (5)
1 (5)
2 (10)
6 (28)
11 (52)

0 (0)
1 (5)
1 (5)
9 (40)
11 (50)

Pain level while getting out of bed?
Very dissatisfied
Dissatisfied
Neutral
Satisfied
Very Satisfied

Pain level while performing light household duties?
Very Dissatisfied
Dissatisfied
Neutral
Satisfied
Very Satisfied

Pain level while performing leisure recreational
activities?
Very Dissatisfied
Dissatisfied
Neutral
Satisfied
Very Satisfied

5.6.3

Expectations

Pre-operatively, expectations were not significantly different between the two groups
(Table 10). Regarding pain relief, 21/21 inpatients and 21/22 outpatients expected the
surgery to help a lot; in terms of improving their ability to carry out normal activities of
daily living, 20/21 inpatients and 19/22 outpatients expected the surgery to help a lot.
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Table 10: Expectations pre-operatively for patients undergoing inpatient and
outpatient total hip arthroplasty
Expectations

Inpatient
(n=21)

Outpatient
(n=22)

Do you expect your surgery will help with pain relief?
A lot
Somewhat
Just a little
No, I do not expect the surgery to help with my pain
Not applicable as I do not have pain

21 (100)
0 (0)
0 (0)
0 (0)
0 (0)

21 (95)
1 (5)
0 (0)
0 (0)
0 (0)

20 (95)
1 (5)
0 (0)
0 (0)
0 (0)

19 (86)
3 (14)
0 (0)
0 (0)
0 (0)

16 (76)
5 (24)
0 (0)
0 (0)

18 (82)
4 (18)
0 (0)
0 (0)

17 (81)
4 (19)
0 (0)
0 (0)

17 (77)
5 (23)
0 (0)
0 (0)

Do you expect your surgery will improve your ability to
carry out the normal activities of daily living?
A lot
Somewhat
Just a little
No, I do not expect surgery to improve my ability
Not applicable as I do not have problems with daily living

Do you expect following surgery you will be able to
participate in similar activities you did before you started
having problems?
As much as before
Not as much as before
No, I do not expect surgery to improve my participation
Not applicable as I do not do sports or recreational activities

Do you expect following surgery the area operated upon
will be back to the way it was before you began having
problems?
Completely
Somewhat improved
A little improved
Not improved

Post-operatively, there were no significant differences regarding the degree to which
expectations were met between the two groups at either six weeks or three months (Table
11). At three months, 16/21 inpatients and 18/22 outpatients believed their expectations
were either met or were too low regarding pain relief, while 17/21 inpatients and 19/22
outpatients believed their expectations were either met or were too low regarding ability
to carry out normal activities.
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Table 11: Expectations post-operatively following inpatient and outpatient total hip
arthroplasty
Time
6 Weeks

Expectations

Inpatient
(n=21)

Outpatient
(n=22)

My expectations for pain relief were…?
Too High – I’m a lot worse than I thought
Too High – I’m somewhat worse than I thought
Just Right – My expectations were met
Too Low – I’m somewhat better than I thought
Too Low – I’m a lot better than I thought

0 (0)
2 (10)
10 (47)
2 (10)
7 (33)

0 (0)
2 (9)
9 (41)
1 (5)
10 (45)

0 (0)
2 (10)
10 (47)
1 (5)
8 (38)

0 (0)
1 (5)
8 (36)
4 (18)
9 (41)

0 (0)
5 (24)
7 (33)
3 (14)
6 (29)

0 (0)
3 (14)
8 (36)
2 (9)
9 (41)

0 (0)
4 (19)
8 (38)
3 (14)
6 (29)

0 (0)
3 (14)
9 (41)
3 (14)
7 (31)

My expectations for being able to do my
normal activities were…?
Too High – I’m a lot worse than I thought
Too High – I’m somewhat worse than I thought
Just Right – My expectations were met
Too Low – I’m somewhat better than I thought
Too Low – I’m a lot better than I thought

3 Months

My expectations for pain relief were…?
Too High – I’m a lot worse than I thought
Too High – I’m somewhat worse than I thought
Just Right – My expectations were met
Too Low – I’m somewhat better than I thought
Too Low – I’m a lot better than I thought

My expectations for being able to do my
normal activities were…?
Too High – I’m a lot worse than I thought
Too High – I’m somewhat worse than I thought
Just Right – My expectations were met
Too Low – I’m somewhat better than I thought
Too Low – I’m a lot better than I thought

5.6.4

Patient Reported Outcome Scores

There were no significant differences between the groups at any time point for EQ-5D,
EQ-5D VAS, WOMAC, Harris Hip, SF-12 and Pain NRS (Table 12). Similar results
were found with non-parametric tests. For each of the scoring measures, both groups
continued to improve at each successive time point, with the exception the MCS
subsection of SF-12, which remained constant throughout the study. Figure 7 presents
unadjusted mean PCS and MCS scores with 95% confidence intervals at baseline, two
weeks, six weeks and three months post-surgery. Figure 8 displays unadjusted mean VAS
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scores with 95% confidence intervals at baseline, discharge, two weeks, six weeks and
three months post-surgery. Mean pain scores improved for both groups at each time point
up until six weeks following surgery. No differences were found when using baseline
pain catastrophizing and self-efficacy scores as a covariate for any of the outcome scores.
Furthermore, there was a weak correlation between LOS and pain catastrophizing scores
for both the inpatient (r = -0.14) and outpatient (r = 0.09), as well as for the self-efficacy
scores for both the inpatient (r = 0.17) and outpatient (r = 0.10).
Table 12: Patient reported outcomes for inpatient and outpatient total hip
arthroplasty (adjusted means). Outcomes include EQ-5D, EQ-5D VAS, WOMAC,
Harris Hip, SF-12 and Pain NRS.
Questionnaire
EQ-5D
Baseline
6 Weeks
3 Months
EQ-5D VAS
Baseline
6 Weeks
3 Months
WOMAC Pain
Baseline
3 Months
WOMAC Stiffness
Baseline
3 Months
WOMAC Function
Baseline
3 Months
WOMAC Total
Baseline
3 Months
Harris Hip
Baseline
3 Months
SF-12 PCS
Baseline

Inpatient
(mean ± SE)

Outpatient
(mean ± SE)

Adjusted Mean
Difference (95% CI)

p-Value

0.79 ± 0.02
0.87 ± 0.01
0.89 ± 0.02

0.77 ± 0.03
0.88 ± 0.01
0.91 ± 0.02

0.02 (-0.04 to 0.09)
-0.01 (-0.04 to 0.02)
-0.02 (-0.08 to 0.03)

0.56
0.44

70.1 ± 4.1
86.8 ± 2.6
85.7 ± 3.4

71.7 ± 4.5
87.2 ± 2.5
93.0 ± 3.3

-1.6 (-14.0 to 10.7)
-0.3 (-7.6 to 7.0)
-7.3 (-16.9 to 2.3)

0.93
0.13

52.4 ± 3.5
88.4 ± 2.6

47.7 ± 3.9
90.8 ± 2.6

4.7 (-6.0 to 15.3)
-2.4 (-9.8 to 5.1)

0.52

46.4 ± 4.5
77.7 ± 3.9

41.8 ± 3.3
82.0 ± 3.8

4.7 (-6.6 to 15.9)
-4.3 (-15.3 to 6.7)

0.43

52.9 ± 4.1
86.5 ± 2.6

47.9 ± 3.3
91.5 ± 2.5

4.9 (-5.7 to 15.5)
-4.9 (-12.2 to 2.3)

0.18

51.3 ± 3.7
85.5 ± 2.6

46.6 ± 2.9
89.2 ± 2.6

4.8 (-4.7 to 14.1)
-3.7 (-11.2 to 3.8)

0.32

59.8 ± 2.1
94.7 ± 1.2

59.8 ± 1.5
97.0 ± 1.2

0.0 (-5.1 to 5.1)
-2.3 (-5.8 to 1.2)

0.19

31.5 ± 1.9

32.5 ± 2.0

-1.0 (-6.7 to 4.6)

58

2 Weeks
35.0 ± 2.2
37.9 ± 2.1
-3.0 (-9.2 to 3.2)
0.34
6 Weeks
46.8 ± 1.7
45.8 ± 1.7
1.0 (-3.9 to 5.9)
0.67
3 Months
48.0 ± 1.7
49.9 ± 1.6
-1.9 (-6.6 to 2.7)
0.41
SF-12 MCS
Baseline
55.1 ± 2.4
54.2 ± 2.2
0.9 (-5.6 to 7.4)
2 Weeks
53.5 ± 2.0
55.7 ± 1.9
-2.2 (-7.8 to 3.4)
0.43
6 Weeks
56.7 ± 1.5
56.9 ± 1.5
-0.2 (-4.5 to 4.2)
0.94
3 Months
57.2 ± 1.7
59.2 ± 1.7
-2.0 (-6.8 to 2.8)
0.41
Pain VAS
Baseline
4.5 ± 0.5
6.0 ± 0.5
-1.4 (-2.8 to -0.1)
Discharge
3.7 ± 0.5
2.6 ± 0.5
1.13 (-0.24 to 2.49)
0.10
2 Weeks
2.2 ± 0.5
1.9 ± 0.5
0.27 (-1.29 to 1.84)
0.72
6 Weeks
0.9 ± 0.2
0.3 ± 0.2
0.62 (-0.06 to 1.31)
0.07
3 Months
1.0 ± 0.4
0.6 ± 0.4
0.47 (-0.74 to 1.67)
0.44
Abbreviations. SE = standard error, CI = confidence interval, PCS = physical component
score, MCS = mental component score
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Figure 7: Short Form-12 scores following inpatient and outpatient total hip
arthroplasty (unadjusted means, 95% confidence intervals), PCS = physical
component score, MCS = mental component score
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Figure 8: Pain Visual Analog Scale (VAS) scores following inpatient and outpatient
total hip arthroplasty (unadjusted means, 95% confidence intervals), DC =
discharge
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5.7 Gait Aid Use
Mean time to discontinue the use of gait aids was 25.5 days ± 23.5 (0 – 95 days) for the
inpatient group and 22.0 days ± 20.1 (0 – 71 days) for the outpatient group. One patient
in the inpatient group and two patients in the outpatient group were still using their gait
aid at their three-month visit post-operatively. One patient in the inpatient group
discontinued the use of gait aids 21 days post-operatively, but presented with a gait aid at
the three-month visit due to pain control issues.

5.8 Phone Calls
There was no statistically significant difference between the two groups regarding the
number of phone calls made to the hospital in the first two weeks post-operatively. The
mean ± SE for the number of calls was 1.1 ± 0.5 (range: 0-11) for the inpatient group and
0.7 ± 0.3 (range: 0-6) for the outpatient group.

5.9 Caregiver Assistance
There was no statistically significant difference between the two groups regarding
caregiver assistance in the first two weeks post-operatively. Most interestingly, on a
seven-point scale, caregivers in both groups reported similar levels of assistance for
transportation (5.2 ± 0.2 vs. 4.9 ± 0.3, mean difference 0.3, 95% CI, -0.5 to 1.1, p = 0.93)
and for household responsibilities (5.0 ± 0.2 vs. 3.7 ± 0.5, mean difference 1.2, 95% CI,
0.2 to 2.3, p = 0.13).
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Chapter 6

6

Discussion

The purpose of this study was to compare serious adverse events and early postoperative
outcomes in patients being discharged either on day 0 (outpatient) or admitted to the
hospital overnight (inpatient) following a primary direct anterior total hip arthroplasty
(THA). We assessed serious adverse events, cost, patient satisfaction, expectations,
functional outcomes, quality of life and pain. In this preliminary analysis of an ongoing
randomized control trial, we found no statistically significant differences in serious
adverse events, whereas the outpatient group had a significantly shorter length of stay
(LOS) in the hospital and was significantly less costly from the perspectives of the
hospital and the Ministry of Health (MoH). No other statistically significant differences
were found between the two groups for any other outcome measures.
The major deterrent for outpatient joint replacements is patient safety, with the fear of
additional adverse events and increase in hospital readmissions. Previous literature that
cautions against outpatient joint replacements advocates that the majority of
complications following surgery occur within the time-frame of the typical hospital
stay100. However, in accordance with research investigating the safety and feasibility of
outpatient joint replacements5,16,101,102, our results illustrate that outpatient THA can be
safely performed with comparable complication rates to similar inpatient procedures. One
patient in the inpatient group (1/21) and one patient in the outpatient group (1/22)
suffered a serious adverse event. Although the sample size is small and definitive
conclusions cannot be made, these results are encouraging.
We compared the cost of inpatient versus outpatient THA from the perspective of the
hospital, MoH and society. Our results illustrate that outpatient THA is significantly less
expensive from the perspective of the hospital ($5,169.76 versus $4,403.30; p = 0.03) and
the MoH ($6,751.59 versus $5,889.92; p = 0.04), while there was no statistically
significant difference from the societal perspective ($12,792.46 versus $14,483.08; p =

62

0.47). Following recovery in PACU, the outpatient group recovered in day surgery
($1.75/min) for an average of 3.3 hours, whereas the inpatient group recovered on the
ward ($0.44/min) for an average of 22.5 hours. Furthermore, the inpatient group had to
stay in PACU ($1.87/min) longer to wait for an available room. The outpatient group was
less expensive primarily due to the decreased LOS (p < 0.001), decreased time in PACU
(p = 0.01) and decreased time in recovery following discharge from PACU (p < 0.001).
Societal costs were similar between the inpatient and outpatient cohorts ($12,792.46
versus $14,483.08; p = 0.47). Although not statistically significantly different, the
outpatient group had more days off of work (32.7 ± 8.2) compared to the inpatient group
(21.1 ± 6.1). Eleven patients in the outpatient group were employed full time, whereas
only eight patients in the inpatient group were employed full time. Furthermore, six
patients in the outpatient group and two patients in the inpatient group reported that they
took three months off of paid employment post-operatively. These discrepancies skewed
the data in favour of the inpatient group but we suspect this difference can be attributed to
our small sample size and that because this is an ongoing randomized trial, these
differences will disappear once the full sample size is achieved. However, in this
preliminary analysis, the cost attributed to days off of work offset the cost savings from
the perspectives of the hospital and the MoH. To make sure any assumptions or estimates
were not influencing the final results, we conducted sensitivity analyses to examine the
degree of uncertainty in the societal costs. We did not find any statistically significant
differences in any of the sensitivity analyses. The only sensitivity analysis that made the
mean difference between groups more similar was when we assigned minimum wage
($11.25 per hour, $90 per 8 hour work day) as the monetary value for patient days off of
work. Time off of paid employment will be important to investigate further in the final
analysis.
At our institution, Petis et al.66 reported that from the perspective of the MoH, the average
total cost of a direct anterior THA (n=40) was $7300.22 (95% CI = 7064.49-7535.95).
Our findings were similar for the inpatient ($6751.59; 95% CI = 5889.10-7611.79) cohort
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and less expensive for the outpatient ($5900.82; 95% CI = 5741.99-6059.66) cohort. The
average LOS reported by Petis et al.66 was 33.9 hours (95% CI = 29.6-38.2), whereas in
our study the median LOS was similar for the inpatient group (29.1 hours; IQR = 6.0),
but shorter for the outpatient (8.4 hours; IQR = 1.1) group.
At our institution, the standard-of-care for THA is a direct lateral approach, which Petis
et al.66 reported as $7853.10 (95% CI = 7577.29-8128.91) with an average LOS of 64.2
hours (95% CI = 56.7-71.7). For this study, we used a direct anterior approach, which has
been shown to allow for accelerated mobility milestones and may therefore be more
amenable to earlier discharge. Indeed, the average LOS for both our inpatient and
outpatient groups was shorter than the direct lateral approach in the Petis study66. Further,
our outpatient group was able to be safely discharged to home on the same day, which is
why the direct anterior approach care pathway with outpatient protocol offer a significant
cost savings over the standard of care direct lateral approach care pathway.
To our knowledge, this is the first economic analysis on outpatient THA conducted in
Canada. Our study found less cost savings compared to other outpatient THA economic
analyses completed in the United States, which can likely be attributed to the
significantly shorter LOS of our inpatient group (24.6 ± 8.9 hours). In 2005, Bertin et
al.10 conducted a non-randomized cohort study with 20 patients (10 patients per group)
and found that the average hospital bill was US$4000 less (p < 0.007) and the average
total charge was US$2465 less (p = 0.02) for outpatients compared to inpatients (LOS =
3.2 days). In our study, the mean difference from the perspective of the hospital was
$766.56 and the mean difference from the perspective of the MoH was $850.77 less for
the outpatients. Other than the longer length of stay in the Bertin study10, four patients in
the inpatient group suffered a complication, whereas there were no complications in the
outpatient group.
A second study by Aynardi et al.3 that used a case-control design to compare inpatients
(n=78) to outpatients (n=119) found that the average overall cost for the outpatient group
was significantly lower than the inpatient group (US$24,529 versus US$31,327; p >
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0.0001). As with the Bertin study10, the average LOS for inpatients in the Aynardi study3
was 73.8 ± 24.1 hours and the average LOS for the outpatients was 24.6 ± 8.9 hours;
much longer than our institution’s practice. Other possible contributions to the
differences between groups (attributed to the study design) include a significantly lower
average BMI (p > 0.0001) and younger age (p=0.07) in the outpatient group3.
One purported advantage of outpatient hip replacements is the increase in patient
autonomy and satisfaction; the majority of patients do not want to remain in hospital and
would prefer to recover in the comfort of their own home16. However, our study found
there was no difference between the two cohorts in any of the satisfaction questions. This
may be a result of our modified Zelen design that blinded patients to the fact that they
were in an RCT and randomized to inpatient or outpatient care, ensuring that satisfaction
was not influenced by positive or negative feelings related to group assignment. It is
worth highlighting, however, that in the outpatient group, two patients indicated that they
felt completely unsafe and unsafe (respectively) upon discharge when moving about the
house or using the bathroom. As our sample size grows we will be better situated to
estimate the magnitude of the problem and whether we need to make changes to patient,
and perhaps caregiver, education material.
Similar improvements were seen between groups in functional ability and quality of life
outcomes. These results were comparable to other outpatient hip replacement studies
assessing clinical outcomes such as EQ-5D, WOMAC, HHS, SF-12 and Pain
VAS8,14,80,102,103. Contrary to our results, Hoeffel et al.104 recently reported significantly
greater improvements in functionality at three months post-operative in outpatients
(n=96) compared to inpatients (n=152). Specifically, outpatients had a significantly
higher improvement using the Oxford Hip score Questionnaire (20.9 vs. 17.0; p < 0.01),
significantly higher improvement in VAS pain score (84.5% vs. 66.2%; p < 0.01),
significantly higher score when rating how normal their joint felt on an 100 point scale
(85.0 vs. 76.8; p = 0.022), and significantly higher percentage of patients reporting their
pain relief (71.7% vs. 56.3%; p < 0.01) and ability to perform regular activities (57.7%
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vs. 30.6%; p = 0.002) as “excellent”104. At the time of our study, Hoeffel’s study was
only a published abstract, which meant that the patient demographics were not explicitly
reported104. In addition, the Hoeffel study was a prospective cohort study without
randomization that compared outpatients undergoing a THA at a newly opened
ambulatory surgery center versus inpatients undergoing a THA in a hospital setting, any
of which could explain the inconsistency in their findings compared to the existing
literature and to our study.
It’s our opinion that patient selection is imperative to ensure outpatient THA is safe. Kort
et al.18 performed a review of the literature to determine the patient selection criteria for
outpatient joint arthroplasty and found that there is no general consensus. The most
common patient selection criteria however included patients who are willing to go home
the same day of surgery, with a low ASA classification (<III), age <75, and sufficient
support at home16,18. Extensive pre-existing comorbidities are a contraindication for
outpatient procedures16,18,76.
The patient demographics of our study were similar to those of a systematic review we
conducted investigating the safety and feasibility of outpatient joint replacements16. In the
systematic review, the mean age for hip replacements ranged from 53-63 years old16. In
the current study, the average age for the inpatient group was 62 ± 8 years (range: 45-79
years) and the average age for the outpatient group was 60 ± 9 years (range: 37-75 years).
However, the average age of the general population undergoing a hip replacement is 68
years16,105, highlighting younger age as an important factor when considering outpatient
care for patients undergoing THA.
The majority of the studies included in the systematic review reported more males than
females16. This is similar to our study, which includes 12 males out of 21 patients in the
inpatient group and 12 males out of 22 patients in the outpatient group. The fact that
studies investigating outpatient care for this patient group have tended to include slightly
more males than females is inconsistent with the fact that slightly more females
(56.8%)16,105 undergo hip replacement than males, which may indicate a surgeon bias
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toward males being better candidates for outpatient surgery. Interestingly, Abbas et al.106
used a multiple regression and found that female gender (p < 0.05) predicted a longer
LOS in the hospital following a total hip replacement. It’s possible that the gender
difference in outpatient joint replacement is due preconceived ideas about sex differences
in societal roles of caregiving where females are thought to more often play a caregiving
rather than care-receiving role16. Although there is no definitive evidence to support this
finding, it is a fascinating trend that should to be examined further.
As Shah et al.107 demonstrated a potential disadvantage to outpatient joint arthroplasty is
the increase in telephone calls from patients to clinicians. Patients admitted to the hospital
following surgery have nurses, physical therapist, occupational therapists and clinicians
available to answer questions as they arise. However, patients who are discharged from
the hospital as an outpatient do not have this same access107. We were cognizant that the
earlier discharge from the hospital might lead to an increase in telephone calls to the
surgeon’s office. However, similar to Goyal et al.102, there was no statistically significant
difference in the number of phone calls between the two groups throughout the first two
weeks post-operatively. The mean number of calls from the inpatient group was 1.5 ± 0.5
(range: 0-11), while the outpatient group was 1.0 ± 0.3 (range: 0-6).
Another perceived disadvantage of outpatient discharge pathway is the fear of shifting the
burden from experienced health professionals to the patient’s caregiver. This theory was
not supported by our data, as the reported number of hours of caregiver assistance was
similar between inpatients and outpatients (25.3 ± 4.2 versus 28.0 ± 5.7; p = 0.71
respectively). One explanation for our findings may be that we only included patients
with an ASA score ≤ 3 (inpatient: 2.2 ± 0.2, outpatient: 2.0 ± 0.1; p = 0.34); patients with
a low ASA score tend to be more self-sufficient and capable of taking care of
themselves108.
We used the Pain Catastrophizing Scale97 and the Self-Efficacy For Managing Chronic
Disease 6-Item Scale98 to potentially explain which patients may encounter greater
difficulty with same day discharge. Sullivan et al.97 found that high scores on the Pain
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Catastrophizing Scale predicted a higher degree of patient-reported pain following
surgery and contributed to a longer duration of disability immediately following the
surgery. Furthermore, individuals who scored high on measures of pain catastrophizing
tended to require a prolonged stay when hospitalized97. However, our study did not
support an association between longer LOS and higher pain-catastrophizing scores for
both the inpatient (r = -0.14) and outpatient (r = 0.09) groups.
Regarding self-efficacy, higher scores indicate patients that are more confident in their
ability to deal with health problems98, which is a crucial trait for outpatients. Our data
did not support an association between longer LOS and lower self-efficacy scores for
both the inpatient (r = 0.17) and outpatient (r = 0.10) groups. However, it’s possible that
our current small sample size and large variability between subjects in self-efficacy
ratings, makes statistically finding a significant association more difficult.
This study is unique for its randomized methodological design, and emphasis on safety,
cost and patient reported outcomes. To our knowledge, this is the first study to randomize
patients undergoing a total hip replacement to either an inpatient or outpatient discharge
pathway. The limited research comparing inpatient to outpatient THA include case series
and non-randomized comparison groups which have a greater potential to introduce
significant bias3,10. Furthermore, the two previous economic analyses involving
outpatient THA had methodological flaws (i.e. non-randomized cohorts, small sample
size and imbalance in patient demographics) and were conducted in the United States3,10.
We conducted an economic analysis from multiple payer perspectives to understand
specifically where cost savings occur. Therefore, this study is important for comparing
inpatient and outpatient THA and can provide surgeons and associated health
professionals with the information needed to make an informed decision when
developing a same-day discharge pathway for patients undergoing a THA.
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6.1 Limitations
The most prevalent limitation was the small sample size, which decreased the precision
of the results. However, this was a preliminary analysis of a larger ongoing study.
Another limitation of our study was that it was completed at a single center with a single
surgeon performing all of the surgeries. The median LOS in Canada following a THA is
four days46, while we used a comparison group with a median LOS of 29.1 hours
(IQR=6.0), which reduces the external validity of our study, as our results may not be
generalizable to the average health care center with longer LOS as part of standard of
care. Furthermore, the use of a single surgeon introduces the possibility of expertise bias,
which can impact procedure time and the availability of a specialized traction table.
With the small sample size of 43 patients, our analysis was overly sensitive to extreme
cases. To avoid presenting a biased estimate of LOS, we were forced to remove one
patient who suffered an intraoperative periprosthetic fracture and required hospitalization
at Parkwood Hospital for over 12 weeks. Since a perioperative fracture is unrelated to the
intervention, this patient was excluded from this analysis and was not analyzed according
to intention-to-treat. Once the study has reached its full sample size, through the process
of randomization, we expect similar proportions of patients within each group to suffer
these types of unrelated complications; leaving the comparison of LOS between groups
uninfluenced.
Logistically, outpatients were scheduled at 8:00 am or 10:00 am to give the patient
sufficient time to meet discharge criteria during the day shift, whereas some inpatients
were scheduled for 12:00 pm. Because at our institution inpatients are usually discharged
at 11:00 am, a surgery at noon for inpatients meant that the LOS for these patients is
shorter than patients scheduled for surgery in the morning (like all outpatients). Thus, the
average inpatient LOS is decreased because of logistics rather than any effect of inpatient
versus outpatient. However, even with this limitation outpatients had a statistically
significant shorter LOS.
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Finally, we originally asked caregivers to complete a questionnaire regarding caregiver
burden following the hip replacement. However, this questionnaire was developed for
caregivers of patients who had suffered a stroke99, which meant that the majority of items
were not relevant to the caregivers in our study since the degree of disability within our
sample was not as great as patients post-stroke. For these reasons, we only reported the
results of questions that we felt were relevant to our population and added a more suitable
questionnaire part way through the study.
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Chapter 7

7

Conclusion

We found no significant differences in serious adverse events between patients who
followed an inpatient versus outpatient care pathway following THA. The outpatient
group had a significantly shorter LOS than the inpatient group, which resulted in
significantly lower costs from the perspective of the hospital and the MoH. Both groups
reported similar scores for satisfaction, pain, quality of life and general health measures.
A larger sample size is required to make any definitive conclusions.

7.1 Future Directions
For this study, we will complete the data collection to include 70 patients in each group
for a total of 140 patients. The larger sample size will strengthen our results and provide
more certainty around our estimates of effect size. Furthermore, we will introduce
additional surgeons at our institution and additional health care centers to limit expertise
bias, improve knowledge translation and increase the study’s applicability.
Future research should include care centers with different patient volumes to ensure that
outpatient THA discharge pathways are manageable across multiple settings and not
strictly within academic centers. Another improvement is to include a caregiver
component that properly assesses whether outpatient caregivers suffer an increased
burden over their inpatient counterparts. Finally, previous research has reported that
numerous surgical techniques can be used to safely and effectively perform outpatient
joint replacements16. In the future, including surgeons that use different surgical
techniques would be beneficial to assess the generalizability of outpatient hip
replacement discharge pathways.
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Appendix C: Letter of Information

Letter of Information
Study Title: Patient Satisfaction and Costs Associated with Total Hip
Arthroplasty
Principle Investigators:
Brent Lanting, MD FRCSC
London Health Sciences Centre
University Hospital
London, ON
519-685-8500 x33335
James Howard, MD FRCSC
London Health Sciences Centre
University Hospital
London, ON
519-685-8500 x33551
INTRODUCTION
You are being invited to participate in a research study because you are undergoing total hip
arthroplasty (THA).
In order to decide whether or not you want to be part of this research study, you should understand
what is involved and the potential risks and benefits. This form gives detailed information about the
research study, which will be discussed with you. Once you understand the study, you will be asked
to sign this form if you wish to participate. Please take your time to make your decision. Feel free to
discuss it with your friends and family, or your family physician.
PURPOSE
The purpose of this study is to evaluate costs and early complications associated with hip
replacement surgery. There will be 70 patients enrolled in this study. Your participation will last
approximately 3 months. Each visit with the surgeon will take approximately 60 minutes of your
time. The length of the visit is not affected by your decision to participate in this study.
DESCRIPTION OF STUDY
The total time commitment of the study is 3 months. Visits for this study will coincide with followup visits that you would already attend with your surgeon after your surgery. We will ask you to fill
out questionnaires that will assess satisfaction, functional ability, quality of life, pain and any
complications. Furthermore, you will be required to keep a diary to capture costs for the first 2
weeks following discharge from the hospital. This diary will ask you to report any emergency room
visits, any hospitalizations; visits to various healthcare professionals; tests, procedures, surgeries;
medications and any cost incurred by your caregiver.

14 April 2015

Page 1 of 4

_______________
Participant’s Initials
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RISKS
There are no known risks to your participation in this study. Participation is voluntary. Standard
anesthetic and surgical risks that apply in standard practice will apply to study participants. There is
no additional imaging, follow-up visits coincide with our standard visit schedule and participants can
opt out of any questionnaires that make them uncomfortable.
BENEFITS
There are no known benefits to you for participating in this study; however, possible benefits may
include decrease in pain levels and increase in function of the hip joint. The findings from this study
will contribute to our improvement in the treatment of future patients undergoing THA. This study
will identify if there is a new, safe and efficient method to THA that can improve satisfaction, while
also minimizing costs.
CONFIDENTIALITY
Any personal health information collected or other information related to you will be coded by a
unique number to ensure that persons outside of the study will not be able to identify you. In any
publication, presentation or report, your name will not be used and any information that discloses
your identity will not be released or published unless required by law. Despite these protections
being in place, there is always a risk of unintentional release of information. The study personnel
will protect your records and keep all the information in your study file confidential to the greatest
extent possible. The chance that this information will be accidentally released is small.
The data that is collected from you is managed by a company called EmPower Health Research. Any
information provided by you is protected by a username and password. It travels in a scrambled
format to a server (storage computer) that is located in Montreal, Canada. Your email address and
your date of birth are part of this database. The database will send automatic reminder emails to you
if you are required to login and answer questions. Instructions for logging into the database will be
provided by the research assistant. The company that houses the database is a professional company
with extremely high standards of physical and virtual security. We want to let you know however,
that even with this high level of security, there is always a remote chance that your information
could be accessed or “hacked” by someone who is not supposed to have your information. If we
became aware that this had happened, we would inform you immediately.
Study data will be kept for seven years. Representatives of the University of Western Ontario Health
Sciences Research Ethics Board may require access to your study-related records or follow-up with
you to monitor the conduct of this research. Representatives of Lawson Quality Assurance (QA)
Education Program may look at study data for QA purposes.
VOLUNTARY PARTICIPATION
Participation in this study is completely voluntary. You may refuse to answer any questions you do
not want to answer and remain in the study. You are free to withdraw at any time without affecting
the quality of the care you receive at this institution, and by signing this form you do not waive your
legal rights. When you withdraw your permission, no new health information will be gathered after
that date. Information that has already been gathered may still be used. If you would like to
withdraw from this study, you will need to provide written or verbal confirmation to the study
coordinator: Michael Pollock, at 519-671-1283.
14 April 2015
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_______________
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COST/COMPENTSATION
There are no additional costs to you for participating in this study. There is no compensation for
participating in this study. The assessments for this study will coincide with your routine follow-ups
with your surgeon.
CONTACT FOR QUESTIONS
If you have any questions about your rights as a research participant or the conduct of this study,
you may contact Dr. David Hill, Scientific Director, Lawson Health Research Institute (519) 6676649.

For more information concerning this study and research-related risks or injuries, you may contact
the Principal Investigator, Dr. Brent Lanting, at 519-685-8500 x33335 or the research assistant
Michael Pollock, at 519-671-1283 or mpolloc5@uwo.ca.
This letter is yours to keep for future reference. Thank you for considering participation in this
study. We appreciate your time and interest.
Sincerely,

Dr. Brent Lanting, MD
Dr. James Howard, MD
Dr. Dianne Bryant, PhD
Michael Pollock, MSc (can.)

14 April 2015
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_______________
Participant’s Initials
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Letter of Consent
Study Title: Patient Satisfaction and Costs Associated with Total Hip Arthroplasty

I have read the Letter of Information, have had the nature of the study explained to me
and I agree to participate. All questions have been answered to my satisfaction. I will
receive a copy of the Letter of Information and this signed consent form.

Printed Name of Participant

Signature of Participant

Date

Printed Name of Person
Obtaining Consent

Signature of Person
Obtaining Consent

Date

14 April 2015
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_______________
Participant’s Initials
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Appendix D: Letter of Debriefing - Inpatient

Letter of Information
Study Title: Patient Satisfaction and Costs Associated with Total Hip
Arthroplasty
Principle Investigators:
Brent Lanting, MD FRCSC
London Health Sciences Centre
University Hospital
London, ON
519-685-8500 x33335
James Howard, MD FRCSC
London Health Sciences Centre
University Hospital
London, ON
519-685-8500 x33551
YOU WERE RANDOMIZED TO: Inpatient
BACKGROUND INFORMATION AND PURPOSE
Patient satisfaction is one of the key components to a successful total hip arthroplasty (THA).
Satisfaction refers to the feeling of achieved expectations with regards to pain and functional
outcome. Furthermore, although THA is an established and proven treatment that frequently yields
excellent results, shortening hospital stays is an important solution to the high cost of hip
replacement surgery. Many important strides have been recently made in arthroplasty, such as
smaller incisions and rapid recovery. The goal of these changes is to provide patients with earlier
control of their independence, while also providing greater relief of anxiety. Rapid rehabilitation and
earlier discharge protocols have allowed patients to feel more control of their body and ultimately
improve their satisfaction. A further potential advantage of shortened length of stay in hospitals is
the decreased cost to the patient and to the healthcare system.
We are interested in evaluating patient satisfaction and costs associated with outpatient versus
inpatient THA. In order to test the effectiveness of length of stay following THA, we must compare
the outcomes of similar patients who receive usual care. The study that you took part in was part of
this clinical trial. A random selection process (similar to flipping a coin) allocated you to the
inpatient group. At the beginning of the study, you were not informed that the random selection
process had taken place as it was felt that this information may influence your perception of the care
you were receiving and your perception of your outcome. Let us reassure you that you received the
same care as patients who were not research participants (usual care). 70 patients took part in this
study, 35 stayed overnight following THA (inpatient) and the other 35 were discharged the same day
(outpatient).

January 20, 2015
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_______________
Participant’s Initials
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RISKS
Standard anesthetic and surgical risks that apply in standard practice will apply to study participants.
Both procedures are currently being conducted in North America and do not represent a new or
novel technique that has not been tested in humans. There is no additional imaging, follow-up visits
coincide with our standard visit schedule and participants can opt out of any questionnaires that
make them uncomfortable.
BENEFITS
You may receive benefit from being part of the outpatient group. The findings from this study will
contribute to our improvement in the treatment of future patients undergoing THA. This study will
identify if there is a new, safe and efficient method to THA that can improve satisfaction, while also
minimizing costs.
CONFIDENTIALITY
If you would like a copy of the study results, please indicate this on the consent form. All information
obtained during the course of this study is strictly confidential and your identity is protected at all
times. You will be identified by a code based on the date of entry into the study and a project
identifier. Data is stored in locked files and is available only to the investigators associated with this
study. You will not be identified in any publication, presentation or reports. Unless your consent is
given, the information or data collected for this study will not be used for any other purpose than for
research. Representatives of the University of Western Ontario Health Sciences Research Ethics
Board may require access to your study-related records or follow-up with you to monitor the conduct
of this research.
VOLUNTARY PARTICIPATION
Participation in this study is completely voluntary. You may refuse to answer any questions you do
not want to answer and remain in the study. You are free to withdraw at any time without affecting
the quality of the care you receive at this institution, and by signing this form you do not waive your
legal rights. When you withdraw your permission, no new health information will be gathered after
that date. Information that has already been gathered may still be used. If you would like to
withdraw from this study, you will need to provide written or verbal confirmation to the study
coordinator: Michael Pollock, at 519-671-1283.
COST/COMPENTSATION
There are no additional costs to you for participating in this study. There is no compensation for
participating in this study. The assessments for this study will coincide with your routine follow-ups
with your surgeon.

January 20, 2015

Page 2 of 4

_______________
Participant’s Initials
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CONTACT FOR QUESTIONS
For more information concerning this study and research-related risks or injuries, you may contact
the Principal Investigator, Dr. Brent Lanting, at 519-685-8500 x33335 or the research assistant
Michael Pollock, at 519-671-1283 or mpolloc5@uwo.ca.
This letter is yours to keep for future reference. Thank you for considering participation in this
study. We appreciate your time and interest.
Sincerely,

Dr. Brent Lanting, MD
Dr. James Howard, MD
Dr. Dianne Bryant, PhD
Michael Pollock, MSc (can.)

January 20, 2015
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Participant’s Initials
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TITLE OF PROJECT: Patient Satisfaction and Costs Associated with Total Hip Arthroplasty
I have read the debriefing letter of information, have had the nature of the study explained to me, and I
agree for my data to be used in the study. All questions have been answered to my satisfaction.

Printed Name of Participant

Signature of Participant

Date

Printed Name of Person Obtaining Consent

Signature of Person Obtaining Consent

Date

Possibility of future research
There may be future opportunities for you to participate in ongoing research. If you are interested in
being contacted, please check the appropriate box below. If contacted, you will be asked to read a
new letter of information and sign a new consent form.
□ Please do not keep my name and contact information. I do not wish to be contacted in the future.
□ Please keep my name and contact information so that I may be contacted to learn about future
research opportunities or have access to my data in the future.
Copy of Study Results
I would like a copy of the study results.
Yes
If yes, please write your mailing address below.

No

__________________________
__________________________
__________________________
__________________________

January 20, 2015
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Participant’s Initials
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Appendix E: Letter of Debriefing - Outpatient

Letter of Information
Study Title: Patient Satisfaction and Costs Associated with Total Hip
Arthroplasty
Principle Investigators:
Brent Lanting, MD FRCSC
London Health Sciences Centre
University Hospital
London, ON
519-685-8500 x33335
James Howard, MD FRCSC
London Health Sciences Centre
University Hospital
London, ON
519-685-8500 x33551
YOU WERE RANDOMIZED TO: Outpatient
BACKGROUND INFORMATION AND PURPOSE
Patient satisfaction is one of the key components to a successful total hip arthroplasty (THA).
Satisfaction refers to the feeling of achieved expectations with regards to pain and functional
outcome. Furthermore, although THA is an established and proven treatment that frequently yields
excellent results, shortening hospital stays is an important solution to the high cost of hip
replacement surgery. Many important strides have been recently made in arthroplasty, such as
smaller incisions and rapid recovery. The goal of these changes is to provide patients with earlier
control of their independence, while also providing greater relief of anxiety. Rapid rehabilitation and
earlier discharge protocols have allowed patients to feel more control of their body and ultimately
improve their satisfaction. A further potential advantage of shortened length of stay in hospitals is
the decreased cost to the patient and to the healthcare system.
We are interested in evaluating patient satisfaction and costs associated with outpatient versus
inpatient THA. In order to test the effectiveness of length of stay following THA, we must compare
the outcomes of similar patients who receive usual care. The study that you took part in was part of
this clinical trial. A random selection process (similar to flipping a coin) allocated you to the
outpatient group. At the beginning of the study, you were not informed that the random selection
process had taken place as it was felt that this information may influence your perception of the care
you were receiving and your perception of your outcome. Let us reassure you that you received the
same care as patients who were not research participants (usual care). 70 patients took part in this
study, 35 stayed overnight following THA (inpatient) and the other 35 were discharged the same day
(outpatient).

January 20, 2015
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_______________
Participant’s Initials
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RISKS
Standard anesthetic and surgical risks that apply in standard practice will apply to study participants.
Both procedures are currently being conducted in North America and do not represent a new or
novel technique that has not been tested in humans. There is no additional imaging, follow-up visits
coincide with our standard visit schedule and participants can opt out of any questionnaires that
make them uncomfortable.
BENEFITS
You may receive benefit from being part of the outpatient group. The findings from this study will
contribute to our improvement in the treatment of future patients undergoing THA. This study will
identify if there is a new, safe and efficient method to THA that can improve satisfaction, while also
minimizing costs.
CONFIDENTIALITY
If you would like a copy of the study results, please indicate this on the consent form. All information
obtained during the course of this study is strictly confidential and your identity is protected at all
times. You will be identified by a code based on the date of entry into the study and a project
identifier. Data is stored in locked files and is available only to the investigators associated with this
study. You will not be identified in any publication, presentation or reports. Unless your consent is
given, the information or data collected for this study will not be used for any other purpose than for
research. Representatives of the University of Western Ontario Health Sciences Research Ethics
Board may require access to your study-related records or follow-up with you to monitor the conduct
of this research.
VOLUNTARY PARTICIPATION
Participation in this study is completely voluntary. You may refuse to answer any questions you do
not want to answer and remain in the study. You are free to withdraw at any time without affecting
the quality of the care you receive at this institution, and by signing this form you do not waive your
legal rights. When you withdraw your permission, no new health information will be gathered after
that date. Information that has already been gathered may still be used. If you would like to
withdraw from this study, you will need to provide written or verbal confirmation to the study
coordinator: Michael Pollock, at 519-671-1283.
COST/COMPENTSATION
There are no additional costs to you for participating in this study. There is no compensation for
participating in this study. The assessments for this study will coincide with your routine follow-ups
with your surgeon.

January 20, 2015
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CONTACT FOR QUESTIONS
For more information concerning this study and research-related risks or injuries, you may contact
the Principal Investigator, Dr. Brent Lanting, at 519-685-8500 x33335 or the research assistant
Michael Pollock, at 519-671-1283 or mpolloc5@uwo.ca.
This letter is yours to keep for future reference. Thank you for considering participation in this
study. We appreciate your time and interest.
Sincerely,

Dr. Brent Lanting, MD
Dr. James Howard, MD
Dr. Dianne Bryant, PhD
Michael Pollock, MSc (can.)

January 20, 2015
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TITLE OF PROJECT: Patient Satisfaction and Costs Associated with Total Hip Arthroplasty
I have read the debriefing letter of information, have had the nature of the study explained to me, and I
agree for my data to be used in the study. All questions have been answered to my satisfaction.

Printed Name of Participant

Signature of Participant

Date

Printed Name of Person Obtaining Consent

Signature of Person Obtaining Consent

Date

Possibility of future research
There may be future opportunities for you to participate in ongoing research. If you are interested in
being contacted, please check the appropriate box below. If contacted, you will be asked to read a
new letter of information and sign a new consent form.
□ Please do not keep my name and contact information. I do not wish to be contacted in the future.
□ Please keep my name and contact information so that I may be contacted to learn about future
research opportunities or have access to my data in the future.
Copy of Study Results
I would like a copy of the study results.
Yes
If yes, please write your mailing address below.

No

__________________________
__________________________
__________________________
__________________________

January 20, 2015
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_______________
Participant’s Initials
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Appendix F: Inpatient Pamphlet
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Appendix G: Outpatient Pamphlet
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Appendix H: Permission from JBJS to Use Systematic Review
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Appendix I: Patient Satisfaction Questionnaire

Patient Satisfaction
Q1. Upon discharge from the hospital, indicate how safe you felt moving about the house, including going to
the bathroom or washing yourself?
Completely Unsafe
Unsafe
Somewhat unsafe
Neither safe nor unsafe
Somewhat safe
Safe
Completely safe

Q2. After surgery, the overall effectiveness of your pain control medications received in hospital at
relieving your pain was:
Completely ineffective
Mostly ineffective
Somewhat ineffective
Neither effective nor ineffective
Somewhat effective
Mostly effective
Completely effective

Q3. After surgery, the overall effectiveness of your pain control medications taken at home in relieving your
pain was:
Completely ineffective
Mostly ineffective
Somewhat ineffective
Neither effective nor ineffective
Somewhat effective
Mostly effective
Completely effective
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Q4. How much stress did you experience due to uncontrolled pain after your surgery? If completing in hard
copy, please mark your pain with a slash across the line ( / ).
No stress 1

100 Extreme stress

Q5. How bad were the side effects from the pain medications you used either in hospital or at home in the
week after surgery (i.e., constipation, inability to void, drowsiness, nausea or vomiting, itching)?
No side
1
effects

100

Extreme
side effects

Q6. In your opinion, how would you rate the overall quality of the nursing care that you received in hospital?
Completely dissatisfied
Mostly dissatisfied
Somewhat dissatisfied
Neither satisfied nor dissatisfied
Somewhat satisfied
Mostly satisfied
Completely satisfied
Q7. Did you have any questions or concerns about your surgery or postoperative care that were not addressed
before your surgery?
No
Yes
So we can improve our education programs in the future, please list your questions:

Q8. . Did you have any questions or concerns about your surgery or postoperative care that were not
addressed after your surgery, but before discharge from hospital?
No
Yes
So we can improve our education programs in the future, please list your questions:
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Q9. Do you feel you were given enough information to know what to expect after you were discharged in
terms of your rehabilitation?
Completely dissatisfied
Mostly dissatisfied
Somewhat dissatisfied
Neither satisfied nor dissatisfied
Somewhat satisfied
Mostly satisfied
Completely satisfied
Q10. Do you feel you were given enough information to know what to expect after you were discharged in
terms of your dressing changes?
Completely dissatisfied
Mostly dissatisfied
Somewhat dissatisfied
Neither satisfied nor dissatisfied
Somewhat satisfied
Mostly satisfied
Completely satisfied

Q11. Do you feel you were given enough information to know what to expect after you were discharged in
terms of the amount of pain?
Completely dissatisfied
Mostly dissatisfied
Somewhat dissatisfied
Neither satisfied nor dissatisfied
Somewhat satisfied
Mostly satisfied
Completely satisfied
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Q12. Consider the length of time you stayed in the hospital. My length of stay was:
I would have preferred to stay another day or two
I would have preferred to stay a few more hours to another day
My stay was just right
I would have preferred to go home a day or a few hours sooner
I would have preferred to go home the same day as my procedure
Q13. Did you receive adequate feedback from your surgeon regarding the results of your surgery (i.e., in the
recovery room, ward)?
Completely dissatisfied
Mostly dissatisfied
Somewhat dissatisfied
Neither satisfied nor dissatisfied
Somewhat satisfied
Mostly satisfied
Completely satisfied
Q14. Was your surgeon available and easily accessible if you needed him or her after your surgery?
Completely dissatisfied
Mostly dissatisfied
Somewhat dissatisfied
Neither satisfied nor dissatisfied
Somewhat satisfied
Mostly satisfied
Completely satisfied
Q15. Please comment on the quality of sleep you achieved on the first night following your surgery
I didn’t get any sleep
I awoke feeling very unrested
I awoke feeling somewhat unrested
Neutral
I awoke feeling somewhat rested
I awoke feeling very rested
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Q16. Overall, I would rate the quality of care that I received before surgery as:
Best care
1
possible

100

Worst care
possible

Q17. Overall, I would rate the quality of care that I received after surgery as:
Best care
1
possible

100

Worst care
possible

Q18. Considering all factors (i.e., preoperative teaching, nursing, doctors, hospital) how satisfied were you
as a patient with the arthroplasty surgery, from the time you first met your surgeon and including up until
the second week after your surgery?
Completely dissatisfied
Mostly dissatisfied
Somewhat dissatisfied
Neither satisfied nor dissatisfied
Somewhat satisfied
Mostly satisfied
Completely satisfied
Q19. How strongly would you feel about recommending this procedure (THA) to a friend or family member?
Recommend to
1
everyone

Never
100 recommend
to anyone

Q20. If you had a choice, how willing would you be to have this procedure (THA) done again under the
same circumstances?
Not at all likely
Slightly likely
Moderately likely
Very likely
Completely likely
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Appendix J: Image Permission

From:
Subject:
Date:
To:

Permissions Permissions.Permissions@cma.ca
RE: Permission to Use Copyrighted Material in a Master's Thesis - Michael Pollock
June 20, 2016 at 2:52 PM
Michael Pollock mpolloc5@uwo.ca

Dear Michael,
You have our permission to use the CJS Figures 1 and 2 in your thesis.
The Royalty fee has been waived.
Please provide credit to the full article.
Janis Murrey

Program Manager Journals
La gestionnaire de programme, Journaux
Joule Inc.
A Canadian Medical Association Company
Une société de l’Association médicale canadienne
1867, prom. Alta Vista Dr., Ottawa ON K1G 5W8
T 800-663-7336
T 613-731-8610 x/poste 2110

joule.cma.ca • joule.amc.ca

From: Michael Pollock [mailto:mpolloc5@uwo.ca]
Sent: June-20-16 2:18 PM
To: Permissions
Subject: Permission to Use Copyrighted Material in a Master's Thesis

Dear Canadian Journal of Surgery:
I am a University of Western Ontario graduate student completing my Master’s thesis entitled “Inpatient versus
Outpatient Total Hip Arthroplasty”. My thesis will be available in full-text on the internet for reference, study
and / or copy. Except in situations where a thesis is under embargo or restriction, the electronic version will be
accessible through the Western Libraries web pages, the Library’s web catalogue, and also through web search
engines.I will also be granting Library and Archives Canada and ProQuest/UMI a non-exclusive license to
reproduce, loan, distribute, or sell single copies of my thesis by any means and in any form or format. These
rights will in no way restrict republication of the material in any other form by you or by others authorized by
you.
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